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CHAPTER 1 PROBLEM STATEMENT IN TOTAL JOINT REPLACEMENT

Total Joint Replacement

In recent years, total joint replacement (TJR) has been raise up critical debate due
to increasing number of revision and replacement surgeries (Kurtz et al., 2007; Carr
and Goswami, 2009).

The major reason is the emerging problems from the materials

used in Total joint arthroplasty (Kendal et al., 2013). Total joint arthroplasty is a highly
reliable and successful surgery that has been performed for decades. TJR implant
materials are mostly bio‐inert and durable substance, such as alloy, bone cement, high
density polymers, etc. (Bahraminasab et al., 2012). However, high risk of implant
failure mostly occurred for earlier wear or infection (Bahraminasab et al., 2012). For
performing over decades, the TJR operation includes replacing the arthritic joint
surface with a hard metal head and soft polyethylene cup, and the stem of implant
was inserted through the trebaculae to the bone marrow cavity, which are cemented
or press‐fit for secure fixation, as shown in Fig. 1.
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Fig.1 A typical total joint replacement prosthesis
The major used metal materials are Ti‐based alloys, stainless steels and Co–Cr–
Mo alloys, and polymers are ultra‐high molecular weight polyethylene. Sometimes
ceramics are substituted for metals, such as alumina, zirconia and their composite.
There components are cemented by Polymethylmethacrylate (PMMA) or press fit to
stabilize the implant. All of these materials are problematic to cause implant failure.
There are numerous causes including excessive wear debris around interface between
bone‐implant, stress shielding in bone and generated soft tissue between prosthesis
and bone due to micro motion, Staphylococcus aureus (SA) induced osteomyelitis, and
so on. All of these causes can be categorized into septic and aseptic stimuli.

Aseptic loosening (AL)

Earlier reports about the extensive localized bone resorption resulting in
loosening without infection was back to 1976 (Harris et al., 1976). Osteolysis was found
directly associated around the area nearby implant surface and has been considered
as the start of implant instability. The explanation in the earlier stage was that particles
disease plays a dominant role in affecting surrounding tissue. This theory has pushing
forward the research of cementless TJR, but the outcome wasn’t turn better as
expected in comparison with cemented implant. This result indicated the AL is a
multifactorial issue.
Schmalzried et al. (Schmalzried et al., 1992) described that wear particles
accessed to the joint fluid entering to the interface between bone and prosthesis.
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Adequate relative movement generated wear particles including cement, UHMWPE,
alloys and bone debris. Wear can occur through five major mechanisms: adhesion,
abrasion, third body, fatigue, and corrosion. The detached particles accelerated metals
or PE wear at the articulation. Followed by more particles fallen off, macrophages
were activated for osteoclastogenesis or differentiated into osteoclast, which initiates
bone resorption. The bone loss will enlarge the gap between implant and bone, which
eases more wear particles into joint fluid and accelerates gradual loosening of the
implant. Another theory from Van der V is that higher pressure of joint fluid moves
the wear debris to effective joint space, which exposes the particles to macrophage
cells resulting in pathogenesis of AL. In any case, wear debris from implant materials
are involved in the initiation of AL.
Polymethylmethacrylate (PMMA) or bone cement are firstly used as fixation
material in hip prosthesis in 1953 (Haboush, 1996). After decades of application,
PMMA cement has become the golden standard approach to fix prosthesis
components for joint replacement. However, long‐term results indicate that
cemented TJR in elderly patients are more satisfactory than younger patients
(Sundfeldt et al., 2006). Debonding between cements and implant is considered as the
main cause of reducing fixation duration. The stem part of prosthesis is in most
frequency of cement debonding, where shear stress occurs all the time. It is notable
that polished stem or uncoated stems are much easier to cause cement debonding
(Sundfeldt et al., 2006). As cement aged, the brittleness of PMMA even elevates and
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the wear debris generation becomes more severe (Howie et al., 1993). For younger
patients with more daily activities, the chance of producing more cement debris in
consequence of more micro‐motion, which in turn cause more severe foreign body
reactions, initiate osteolysis and loosening.
Ultra‐high molecular weight polyethylene (UHMWPE) is the most commonly used
polymer as bearing resistance or abrasion resistance materials on implant surface. The
oxidation of PE will induce its degradation. The original smooth surface of PE that
reduce friction and wear becomes rough and easy to wear down after oxidation
degeneration (Sundfeldt et al., 2006). Super fine and irregular shape PE wear particles
induced severe inflammatory response and subsequent osteolysis (Ren W.P et al., 2003;
Ren et al., 2006).
Metals and their alloys, represents a large variety of engineering materials in
application in medical device and implants (Bahraminasab et al., 2012). Stainless steel
has been widely employed as orthopaedic implant for its easy availability, high
strength, lower cost, easy fabrication, etc. (Sangeetha et al., 2010; Majid et al., 2011;
Taira and Lautenschlager, 1992). However, the weakness of lower wear resistance
limits its application. Moreover, the poor adherence to surrounding bone further
increases the risk of inducing AL. The ion release from stainless steel in human body
because of corrosion fatigue, cracking, pitting is another concern (Singh and Dahotre,
2007). Both Al and V released from implant are related to health problems, such as
Alzheimer disease and neuropathy (Navarro et al., 2008; Okazaki and Gotoh, 2005). Ti
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and its alloy have excellent properties including high strength, low density, resistance
to corrosion, bioinert and son on. Ti related implants are advantageous since Ti is
capable to integrate to surrounding bone, which is considerable for long‐term fixation
and avoid micro‐motion. However, the shortcomings of Ti are still obvious. Though
lower than stainless steel or CO‐Cr alloys, the elastic modulus of Ti is still way out of
the range of natural bone, which cannot reduce the stress shielding effect. Moreover,
when Ti rubbed against itself or other materials, severe wear occurred (Nasser et al.,
1990). The metallic wear particles cause adverse effect such as tissue blackening and
metallosis (Dearnley, 1999). Therefore, the application of Ti and its alloy was restricted
to area where wear resistance is not dominant. Cobalt‐based alloys are superb in
mechanical strength including high resistance to fatigue and corrosion induced
cracking, which used mostly in stem of prosthesis for heavy load purpose. However,
Co‐Cr alloys with extreme high elastic modulus of about 240 GPa, causes stress‐
shielding effect and subsequent AL. Moreover, Co‐Cr alloys has poor adherence to
surrounding bone, and the released ions from Co‐Cr are even more toxic than stainless
steel.
In summary, the current used materials for joint replacement are vulnerable to
fulfill some vital requirements, which mostly lead to long‐term problems including AL.
Researches has been carried on to explore alternative or new approach to replace or
improve existing materials.
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Septic loosening (SL)

Bone and joint infection or osteomyelitis is painful complication that it is
extremely hard to treat. The successful rate of antimicrobial therapies in other
infectious disease was not well applied in bone and joint infections (Lew and
Waldvogel, 2004). Effective treatment usually involves a combination of implant
removal, extensive debridement, and two‐stage re‐implantation, often with use of
antibiotic spacers and cements. There is a clinical challenge for local antibiotic delivery
including insufficient antibiotic content and burst drug release.

Osteomyelitis is a

microorganism induced inflammatory process accompanied with osteolysis and bone
degeneration (Waldvogel et al., 1970). Osteomyelitis most commonly followed a
continuous spread of contamination from trauma, bone surgery and joint
replacement. The mechanism of the osteomyelitis is demonstrated to be associated
with inflammatory response to invaded microorganism or bacteria.
Numerous inflammatory factors were induced by leucocyte, which were involved in
necrosis of tissue and dissolving bone tissue. Bone debris channeled by blood supply
formed sequestra and continue to provide colony space for bacteria growth, as shown
in Fig.2. It is hard for antibiotics to reach to the infected site. Once infection becomes
severe, osteoclasts were always associated to digest bone tissue and increase
osteoporosis.
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Fig.2 Illustration of osteomyelitis
The cause of osteomyelitis is associated with various microbial and host factors.
Staphylococcus aureus (SA) is by far known as the most common microbial involved in
osteomyelitis. The adhesion of SA to prosthesis surface is considered as the most
crucial step for bacterial colonization and infection in early stage. SA has specific
adhesins on its surface that enable to interact with host proteins, such as fibrinogen,
fibronectin, collagen, vitronectin, laminin, thrombospondin, bone sialoprotein, elastin,
etc. SA can also form biofilm, which is hard to treat by antibiotics. Due to the difficulty
to distinguish mechanical loosening and infectious loosening in the earlier period of
joint replacement, the current technology to diagnosis osteomyelitis is still need to be
improved.
The medical management of osteomyelitis is well developed. Antibiotic
prophylaxis has been used successfully to prevent wound infections after surgery
(Boxma et al., 1996). Standard preoperative preparations (including antimicrobial
shower, shaving, and soap‐disinfectants) are also considered as effective to reduce
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the risk of surgery infection (Lucet et al., 1990). Antimicrobial therapy is strictly
administered via antistaphylococcal penicillins or first‐generation (cefazolin), or
second‐generation (cefamandole and cefuroxime) cephalosporins decrease the rates
of postoperative infection (Classen et al., 1992). However, this treatment carries risks
of complications associated with a long stay in hospital and adverse events due to the
use of intravenous catheters, as well as associated personal and economic costs from
the extended hospital stay. The current approach to treat infected prosthesis is
complete removal of the implant and replace with new one, which is high cost and
suffering to patients. Therefore, a sustainable local delivery of antibiotics from
prosthesis that can effectively inhibit bacteria growth is highly demanded.

CHAPTER 2 CURRENT APPROACHES
Background

Each year, over 700,000 total joint replacement (TJR) operations (hip and knee)

9

are performed in the US (Berry et al., 2002), and the number continues to increase
with an aging population. Aseptic loosening (AL) is the most common cause of TJR
failure and its incidence continues to increase(Kroell et al., 2009). Implant stability and
a long‐term survival of TJR require early osseointegration (the direct anchorage of an
implant by bone formation at the bone‐implant surface).

An early and rapid

osseointegration requires the recruitment of bone marrow stromal cells (BMSCs) to
the periprosthetic site(Lee and Goodman, 2008). After surgery, the gap between the
implant surface and surrounding bone needs to be completely bridged by newly
formed bone. There is compelling evidence that a defective implant osseointegration
(the formation of a piece of fibrous membrane between the implant surface and
surrounding bone) leads to implant instability, micromotion, osteolysis and loosening
(White et al., 2012b; Boos et al., 2008).

Kärrholm et al.(Karrholm et al., 1994)

reported that the subsidence of the implant is associated with an increased risk of AL.
Ryd et al.(Ryd, 1992) proposed that the occurrence of implant instability and
micromotion represent two of the risk factors of early implant loosening in both knees
and hips. The rate, quantity and quality of osseointegration are closely related to the
physiochemical and biological properties of the implant surface (de Jonge et al., 2008).
More efforts are required to develop a “bone like” implant surface that shows
potential for implant osseointegration.
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Fig. 3 Current approaches of prosthesis fixation: (left) cemented and (right) biological
coating
Wear debris induced aseptic loosening (AL), which is associated with the presence
of a macrophage response to wear debris particles accumulated at the interface
between the implant component and the surrounding bone, is considered as a major
cause for orthopaedic prosthesis failure (Bullough et al., 1988). The greatest numbers
of macrophages were present in membranes from patients in all cases were associated
with the presence of wear debris (stainless steel, chrome cobalt particles, PMMA, etc.)
(Lennox et al., 1987). Biological coatings, or so called cementless porous coatings was
deposited biomimetic Ca‐P ceramics on implant surface to attempt to overcome the
limitations of cement fixation. Cementless porous coating that avoids screw fixation
may prevent potential egress of polyethylene particles through the shell decreases the
amount of polyethylene wear debris introduced to the pelvis. However, the limitations
of cementless coatings are still obvious for the brittleness, poor adhesion strength, etc
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(Xu et al., 2006). Therefore, development of a “bone‐like” interface between implant
and surrounding bone tissue that provides reliable mechanical support would
significantly reduce the risk of AL.

Fig.4 Illustration of S. aureus induced osteomyelitis
From another aspect, implant infections represent the most feared complications
in orthopedic surgery(Perka and Haas, 2011) that eventually cause the implant failure.
The incidence of periprosthetic infection after TJR (hip and knee) is > 2% among the
Medicare population (Kurtz et al., 2010; Ong et al., 2009). This is a large number
considering approximately 581,000 total knee and more than 193,000 total hip
replacements are performed each year in the US alone. The incidence of periprosthetic
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infection is higher after revision surgery than after primary surgery. Furthermore, 15%
of hip revisions and 25% of knee revisions are due to implant infection (Bozic et al.,
2009). Implant infection causes loss of supporting bone, as shown in Fig.4. Bacteria
including Methicillin‐resistant Staphylococcus aureus (MRSA) have a high affinity to
bone, leading to osteonecrosis and osteolysis. Treatment usually requires that the
implant be entirely removed, the surrounding tissue cleared of infection, and then a
second prosthetic device is implanted. This can take months and an average of $50,000
per case. MRSA is one of the leading pathogens involved in periprosthetic infection
(Pulido et al., 2008). The percentage of prosthetic infection with MRSA is increasing
and the death rate from MRSA is 2.5 times greater than from non‐resistant S. aureus
infection (Fry and Barie, 2011). MRSA adhere to the implant surface, replicate and
become embedded within a self‐produced matrix of extracellular polymeric substance
(biofilm) (Xu and Siedlecki, 2012). Numerous strategies have been attempted to
prevent bacterial adhesion and biofilm formation by either implant surface fabrication
or incorporation of antibiotics into the implant devices for local administration
(Kankilic et al., 2011; Simchi et al., 2011a). Thus, to develop a bactericidal implant
surface that provides a local sustained delivery of antibiotics to the bone/implant
interface are highly demanded.
To summarize, our study is targeting on developing a bioactive and biocompatible
substrate covering the orthopaedic implant surface to promote osseointegration,
prevent wear‐debris induced AL and inhibit osteomyelitis.
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Current approaches

Hip implants may be cemented, cementless (press‐fit) or a combination of both,
depending on the method used to hold the implant in place. A cemented hip implant
is designed to be used with bone cement, which was first used in hip replacement in
1961. First, the femoral canal is prepared and then bone cement is introduced into the
femur. The surgeon then positions the implant within the femoral canal and the bone
cement helps to hold it in the desired position, providing initial fixation. Cemented
implants are more commonly used in older patients, patients with rheumatoid
arthritis or younger patients with poor bone quality.

Fig.5 Cemented and Press‐Fit Hip prosthesis
A press‐fit hip implant is designed to be inserted into the prepared femoral canal
without the use of bone cement, as shown in Fig.5. Press‐fit fixation has been utilized
in total hip replacement since as early as 1943. Initially, the femoral canal is prepared
in much of the same way as a cemented hip implant; however, a press‐fit implant is
designed so that the implant fits tightly into the canal at the time of surgery. The rough
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surfaces on the press‐fit hip implant are designed to engage the bone within the canal,
permitting bone to grow onto the roughened surface of the implant. Press‐fit implants
are more commonly used for younger, more active patients and patients with good
bone quality.
In conclusion, new materials and technologies are therefore developed to fulfill
the requirements from total joint replacement. Despite the advance in coating or
spraying technologies was rapid, a completed solution to overcome the shortcomings
of AL / SL induced TJR failure is still absent. Thus, there is an urgent need for a multi‐
functional biomaterial as a “bone‐like” interface that can be developed to match
biological, physiochemical and clinical requirements to integrate the bone tissue and
implant components.
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CHAPTER 3 PVA‐HA‐COLLAGEN HYDROGEL BIOLOGICAL COATING
Introduction

Implant fixation and the long‐term survival of a TJR require a functional and
“bone‐like” implant surface matrix that will support the initiation of periprosthetic
osseointegration.

Basic science research and clinical trials have indicated that

hydroxyapatite (HA) coating on the implant surface can enhance both the bone
ingrowth and bony apposition (Geesink et al., 1987; Kim et al., 2003; Landor et al.,
2009; Massaro et al., 2001; Race et al., 2010; Shepperd and Apthorp, 2005; Yoon et al.,
2007; Mai et al., 2010; Gracia et al., 2010; Springer et al., 2009). However, the non‐
physiological surface of HA coating leads to diminished initial osseointegration of
implanted prostheses (Goosen et al., 2009; Chung et al., 2008). An additional limitation
of HA coating includes its brittle nature (Song et al., 2010a; Leeuwenburgh et al., 2006;
Ning and Dai, 2003).
Natural bone is composed of nanohybrid organic–inorganic components
shown in Fig.6. The organic matrix is mainly type I collagen (Col) which provides bone
its flexibility and resilience, and the inorganic phase is composed of the mineral
hydroxyapatite (HA) which is responsible for the stiffness and strength of bone. The
organic–inorganic constituents combine together to provide a mechanical and
supportive role in the body (de Jonge et al., 2008). It has been a long‐term goal for
biomaterial scientists to fabricate a “bone‐like” HA coating surface that mimics the
biological, structural and mechanical behavior of natural bone (de Jonge et al., 2008).
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Col and HA have potential in mimicking natural bone matrix. It has become a rapidly
expanding research area since a synthesized HA and Col composite could be applied
for better bioactive bone graft for bone repair (Dawson et al., 2008; Wahl et al., 2007).
The combination of both a ceramic and a protein polymer within one material is
expected to enhance the adhesion, proliferation and differentiation of osteogenic cells
(osteoblast and osteoblast precursor cells), thereby offering a benefit over current
non‐physiological HA coating.

Fig.6 Bone tissue from microstructure to molecular structure
Polyvinyl alcohol (PVA), a water‐soluble polymer, has been used extensively as
a scaffold supporting material for tissue engineering applications. It endows
mechanical strength and safety (Ngawhirunpat et al., 2009; Sailaja et al., 2009). We
propose that PVA represents a promising scaffold coating material because of its
biocompatibility, proven mechanical strength and anabolic effect on bone formation
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(So et al., 2007; Matsumura et al., 2009; Ngawhirunpat et al., 2009; Sailaja et al., 2009).
In addition, PVA hydrogels have been used in a number of biomedical applications
including soft contact lenses, cartilage implants, drug‐delivery matrices, temporary
skin covers or burn dressings and artificial organs. This is because of their inherent
non‐toxicity, non‐ carcinogenicity, good biocompatibility, and desirable physical
properties such as rubbery or elastic nature and high degree of swelling in aqueous
solutions.

Since pure PVA is bioinert and has limited capability to interact with the

bone microenvironment, we propose to develop a “bone‐like” PVA coating by
incorporation of both Col and HA.
The objective of our study was to develop biodegradable PVA/Col/HA
composite hydrogels to mimic the topological structure of human bone tissue. The
physiochemical properties of the hydrogels (viscoelasticity, swelling, stability,
mechanical strength, and embedded erythromycin release dynamics) were described.
In addition, the in vitro cellular behaviors of both osteoblastic MC3T3 cells and RAW
264.7 monocytes grown on the PVA/Col/HA hydrogel composites were examined.

Materials

PVA (Mw~205,000), HA (<200 nm particle size), Col type I (from rat tail) and
erythromycin were purchased from Sigma‐Aldrich (St. Louis, MO). Murine MC3T3‐E1
preosteoblast cell line and murine RAW 264.7 macrophage cell line were obtained
from ATCC (Manassas, VA). Alpha‐modified minimum essential medium (α‐MEM) was
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purchased from Invitrogen (Carlsbad, CA). Alkaline phosphatase (ALP) assay kit was
from

BioVision

(San

Francisco,

CA).

3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐

diphenyltetrazolium bromide (MTT) assay kit was from ATCC (Manassas, VA). Bovine
albumin conjugated to fluorescein isothiocyanate conjugate (Albumin FITC) was
purchased from Sigma‐Aldrich (>7% mol FITC albumin). Ultrapure water (DNAse,
RNAse Free, 0.1 micron filtered) was purchased from Invitrogen Corp.
Preparation of PVA/HA/Col hydrogel
Aqueous solutions of 13 wt.% PVA was prepared by dissolving pre‐weighed
quantities of PVA in distilled water and heating for 6 h at 90°C. Pre‐weighed HA
nanoparticles were then added to the PVA solution and thoroughly homogenized by
stirring at 60°C for 4 hours at various HA/PVA ratios (w/v) (4%, 7%, 10% and 15%). The
PVA solution was cooled slowly to room temperature. Then Col was mixed with the
HA/PVA emulsion by stirring at room temperature to form a PVA/HA/Col solution with
a final Col percentage of 13% (v/v). Secondly, 150 μL of PVA/HA/Col solution was cast
into each well of a 24‐ or 96‐well cell culture plate (Corning, Lowell, MA) until it was
spread smoothly to form a coating. A freeze‐thaw (F‐T) treatment was used to
physically crosslink the coated hydrogel. Briefly, coated plates were frozen at ‐20°C
overnight and slowly thawed in a sterile hood (Labconco, Kansas City, Missouri) with
the UV light on. The number of F‐T cycles ranged from 1 to 3 (C1, C2 and C3,
respectively) to prepare hydrogels with different degrees of crosslinkage. In this study,
two types of coated hydrogel samples with different dimensions were separately

19

prepared for different assays. The thinner one (1.9 cm2 × 0.1 cm) was prepared from a
24‐well plate, while the thicker one (0.3 cm2 × 0.5 cm) was prepared from a 96‐well
plate. Both types of hydrogels were air‐dried in a sterile hood until weights were
comparable.
Rheology of PVA/HA/Col hydrogel
An AR2000 rheometer (TA Instruments Inc., New Castle, DE) with a standard steel‐
parallel‐plate geometry of 20 mm diameter was used for the rheological
characterization of PVA/HA/Col hydrogels with (C3) or without F‐T treatment before
air‐drying. Test methods of oscillatory stress sweep and frequency sweep were
employed. The stress sweep was performed at a constant temperature (25°C) and
frequency constant (2π rad/s) while increasing the stress level from 0.01 to 100 Pa. The
linear viscoelastic region (LVR), from 0.01 to 100 Pa, was determined as safe region
without structural breakage from oscillatory stress. Samples were subjected to a
steady stress ramp and the corresponding storage modulus (G’) and loss modulus (G”)
were measured. The frequency sweep was performed at a fixed stress corresponding
to the point in the middle of the LVR profile. The oscillatory frequency was increased
from 0.1 to 100 rad/s, and the plots of G’ and G” toward frequency were obtained from
manufacturer‐provided software. Complex viscosities (η*) were obtained from a flow
test to plot against frequency as well.
Mechanical testing
The aforementioned thicker hydrogel samples for mechanical testing were
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prepared with (C3) or without F‐T treatment. These samples were tested in unconfined
uniaxial compression using a universal servohydraulic test machine (Instron 4302,
Norwood, MA) at a speed of 0.01 mm/sec. The maximum strain level was set to be 0.5,
where the failure of the specimens was well observed. The engineering compressive
stress (σ) ‐ strain (ε) curve relationship was calculated from the Instron linear variable
differential transformer (LVDT) and load cell measurements. Each group was measured
in triplicate.
Swelling of hydrogels
Gels were allowed to dry in a sterilized hood until drying was complete (as verified
by no change in gel weight) before swelling. For all swelling experiments, each initial
hydrogel coating film was gently torn off and allowed to swell in 3 mL of sterile water
at 37°C overnight. After the supernatant was discarded, samples were weighed as
W(wet). Samples were then dried again and weighed as W(dry). Thus, the amount of
water uptake (WU) was measured to evaluate the swellings by WU (%) = 100 x
(W(wet)‐W(dry))/W(dry). The initial weight of gels before swelling was also measured
as reference. To further study the biomolecule‐loading capability of PVA hydrogels, the
incorporated Albumin FITC released from hydrogels into aqueous solution was
quantified. Albumin FITC was encapsulated into PVA/HA/Col hydrogels by thorough
homogenization during preparation. The PVA/HA/Col/Albumin FITC hydrogel was
soaked in PBS at 37 ºC. The fluorescence intensity of supernatant was measured at
each time interval of 0, 2, 4, 6, and 24 h via a UV/VIS Spectrophotometer at 485/528
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(excitation/emission) nm (BioTek Synergy HT).
Bactericidal activity assay
In order to evaluate the drug delivery capability of PVA/HA/Col hydrogels, a 14‐
member lactone ring macrolide antibiotic, erythromycin (EM), was incorporated
during hydrogel preparation. Briefly, a EM‐ethanol solution was gently added to PVA
and homogenized thoroughly with an ultimate concentration of 50 μg/mL (final
ethanol concentration was < 1%). The hydrogel was used to coat a petri‐dish (d=35
mm) instead of wells in a 24‐ or 96‐well plate for this assay and F‐T for 1, 2, and 3 cycles.
A modified minimum inhibitory concentration (MIC) assay was developed to measure
the bactericidal activity of released EM from the hydrogel. First, a Mueller–Hinton
broth inoculated with Staphylococcus aureus (S. aureus) at the concentration of 1–2
×108 colony forming units/ml (CFU/ml) (OD reading at 625 nm was around 0.08‐0.1)
was prepared. Second, 2 mL of sterile PBS was added to the coated petri‐dish and
incubated at 37°C. Supernatant was withdrawn at 5, 24, 29, 49, 121 and 194 h and
immediately added to 1 mL bacteria‐suspended broth (OD=0.1). The bacterial
suspensions were further incubated at 37°C overnight and then measured. The
bactericidal activity was evaluated by dynamic measurement of OD reading at 625 nm
(Song et al., 2011b). Bacterial culture suspension in the absence of EM was included
as a positive control.
Culture of MC3T3 and RAW 264.7 cell lines
MC3T3 cells were seeded at a density of 5×104 cells/well (24‐well plate) onto the
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surfaces of coated PVA/HA/Col hydrogels. MC3T3 cells were then cultured for 11 days
in α‐modified minimum essential medium (α‐MEM, Invitrogen) supplemented with 10%
fetal bovine serum (FBS, Invitrogen), 10 mM β‐Glycerophosphate (Sigma Aldrich), and
1% (v/v) mixture of penicillin and streptomycin (Invitrogen) at 37ºC in a humidified
incubator with 5% CO2. In separate experiments, RAW 264.7 cells were seeded on the
coated hydrogels at a density of 5×104 cells/well (24‐well plate) onto the surfaces of
coated PVA/HA/Col hydrogels. RAW 264.7 cells were then cultured in Dulbecco’s
modified Eagle’s medium (DMEM, Invitrogen) supplemented with 10% FBS (Invitrogen)
and antibiotics (1% (v/v) mixture of penicillin and streptomycin) for 72 hours. Cells
cultured in the absence of PVA/HA/Col hydrogels were included as controls.
MC3T3 cellular response
Cytotoxicity was determined by measuring the release of lactate dehydrogenase
(LDH) from dead or dying cells into the culture medium by colorimetric method
following the manufacturer’s instruction (Roche Diagnostics BmbH). Blank culture
medium was used as a blank control and the total cell lysate was used as a positive
control. LDH activity was expressed as mean optical density (OD). Attachment and
proliferation of the murine osteoblastic MC3T3 cell line on PVA/HA gel matrices were
investigated by measuring the content of MTT (3‐(4,5‐Dimethylthiazol‐2‐yl) ‐2,5‐
diphenyltetrazolium bromide) in cell lysates from the gel. The influence of HA
incorporation, HA ratio and F‐T cycles on cell viability was investigated via LDH and
MTT assays.
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After seven days in culture, the cells were stained using a live/dead cell viability kit
(Invitrogen). The effects of HA and EM incorporation, HA ratio, collagen content, etc.
on MC3T3 cells’ viability were investigated. To induce MC3T3‐E1 cell differentiation,
the basic medium was supplemented with 0.2 mM ascorbic acid and changed every 3
days. After culturing 11 days, the cells (ALP assay buffer 250 μl/well) were harvested
to collect lysate for the ALP assay according to manufacturer’s protocol.
RAW 264.7 cellular response
The nitrite (NO2‐) concentration released from RAW 264.7 cells was measured to
investigate the macrophage activation (Bosnjakovic et al., 2011). Instead of using
lipopolysaccharide stimulation, PVA/HA/Col hydrogel was mixed with seeded RAW
cells as inducers for macrophage activation. After culturing for 72 h, cell culture
supernatants were analyzed for nitrite (NO2‐) by the Griess reaction (Green et al., 1982).
Briefly, 80 μL of collected medium were mixed with 40 μL of Griess Reagent 1 (1%
solution of sulfanilamide in 5% phosphoric acid) and 40 μL of Griess Reagent 2 (0.1%
solution of N‐(1‐napthyl)ethylene‐diamine in H2O) at 25ºC and kept in the dark for 15
min before the OD was determined. Fresh culture medium was used as the blank in all
experiments. The amount of nitrite was calculated from a sodium nitrite standard
curve.

Statistical analysis
Data were analyzed with SPSS Version 12.0 (SPSS Inc., Chicago, IL, USA). All values
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are expressed as mean ± standard deviation. Analysis of Variance (ANOVA) was used
to analyze the experimental data from all the experiments. Statistical significance was
set to p <0.05.

Fig. 7 Rheological properties of PVA/Col/HA gels before and after F‐T treatment (C3);
HA content = 10%. Storage modulus (G’) and loss modulus (G’’) profiles across: (a) a
oscillatory range of 0.01–100 Pa at 25°C; (b) a frequency sweep of 0.1–100 rad/s at
25°C, and (c) complex viscosity across a frequency sweep of 0.1–100 rad/s at 25°C.

Results
Rheological properties of hydrogel
Fig. 7(a) shows the storage modulus (G’) and loss modulus (G”) independence of
oscillation stress sweep for the applied non‐destructive stress on F‐T (C3) and non‐F‐T
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PVA/Col/HA hydrogel before air‐drying. In the stress range from 0.01 to 100 Pa, the
non‐F‐T gel showed higher G” than G’, indicating the prevalence of viscous fluid
behaviors, while the F‐T gel showed higher G’ than G”, indicating the dominant
elasticity. The conversion of G’ over G” of the hydrogel after F‐T suggested the
formation of an intermolecular network structure. Fig. 1 (b) shows the G’/G”
dependence of the frequency sweep with fixed stress load on F‐T (C3) and non‐F‐T
hydrogels. The viscoelastic behaviors of both samples were in agreement, as both
showed stress sweep. An increase in both G’ and G’’ as the frequency increased was
revealed and the decrease of G’ slope along with the frequency decrease suggested
the weakly structured system in the F‐T hydrogel. The merging of G’‐G” plot at higher
frequencies (>10 rad/s) indicated the breakage of network structure for the F‐T
hydrogel. As shown in Fig. 1 (c), the complex viscosities (η*) of the F‐T hydrogel were
decreasing across the frequency range (indicating pseudoplastic behavior), while the
η* of the non‐F‐T hydrogel showed independence from frequency change (indicating
a non‐cross‐linking structure). The dismantling of structural linkage caused by higher
frequencies of shear stress was more significantly revealed as the η* decrease of F‐T
hydrogel. Taken together, the F‐T process was capable of forming a cross‐linked
structure in the PVA/Col/HA hydrogel, which modified its viscoelasticity.
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Fig. 8 (a) Swelling properties of PVA/Col/HA gels after 1, 2 and 3 cycles of F‐T
treatment and (b) quantification on fluorescence intensity of released albumin FITC
from PVA, PVA/Col/HA and PVA/Col/HA/EM gels; HA content = 10%. n=3, *p<0.05
for C3 versus C1 and C2.
Swelling property and FITC release from hydrogels
All PVA/Col/HA hydrogels prepared by F‐T (C1, C2 and C3) treatments were
swelled in water to evaluate the swelling and dissolution behaviors. The percentage of
water uptake can be considered as proportional to the swelling ratio of hydrogel, as
shown in Fig. 8 (a). It can be seen that the swelling ratio of hydrogel was decreased
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with the increase of F‐T cycles. Hydrogel treated for 3 cycles of F‐T (C3) showed the
minimum water uptake amount, which suggested the least swollen structure. The
increased F‐T cycles lead to increased physical cross‐linking and therefore higher
degrees of crystallinity (Hassan and Peppas, 2000b).

Thus, the immobility of

molecules in hydrogel with higher cross‐link density and crystallinity limited the
swelling ratio of hydrogel treated by more F‐T cycles.
The measurement of incorporated Albumin‐FITC releasing into the culture
medium demonstrated the extended release of entrapped components, as shown in
Fig. 8 (b). The FITC fluorescence signal in PBS constantly decreased during the 24‐hour
incubation, while FITC released from the PVA gel peaked at 2 h before decaying
gradually. FITC entrapped in PVA, PVA/Col/HA and PVA/Col/HA/EM all released in the
same pattern.
Mechanical property of hydrogels
Fig. 9 (a) shows the measured stress‐strain for compressing the PVA/Col/HA
hydrogel with (F‐T) or without F‐T (non‐F‐T) treatment. It showed that the stress vs.
strain curve of F‐T hydrogel went over a linear elastic region of <10% strain, and a
logarithmic plastic or densification region after stress yielding point under further
loading. In comparison, the slope of non‐F‐T hydrogel in elastic region was smaller, and
stress level was lower, which indicated the softer nature in content. After the yield
point, both F‐T and non‐F‐T hydrogels continued deformation on account of strain
hardening in a similar pattern and slope. The integral of the stress–strain curve
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represents a specific energy (energy per unit volume) that the hydrogel structure could
absorb. F‐T hydrogel showed higher energy absorption capability during loading stage.
Fig. 9 (b) showed the F‐T hydrogel maintained a higher Young’s modulus as well, as
calculated from the linear curve in elastic region.

Fig. 9 (a) The compressive stress (σ) ‐ strain (ε) curves and (b) calculated Young’s

29

modulus of PVA/Col/HA gels without and with F‐T treatment (C3). n=3, **p<0.005
related to F‐T against Non‐F‐T.
Bactericidal activity
EM, one of the macrolide antibiotics, has been used for infectious diseases for
more than 50 years. EM is susceptible to loss of its bactericidal activity in the acidic
environment. We incorporated EM into the PVA/Col/HA hydrogel using 1, 2 and 3
cycles of F‐T treatments to study its bactericidal activity after release. In Fig. 10, the
results of a semi‐quantitative bactericidal activity assay shows the bacterial growth
was inhibited by EM released during culturing, which suggested hydrogels treated by
different F‐T cycles were capable of retaining the drug stability before release.
Moreover, medium from hydrogel treated with 3 F‐T cycles showed significantly higher
inhibitory effect (p<0.05) within 29 h on bacterial proliferation, which indicated the
longer sustained release. Bacterial growth was suppressed for over 49 h of culture,
suggesting the EM stability released from hydrogels. These data indicated that EM
retained longer durability and bactericidal activity in PVA/Col/HA hydrogel.
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Fig. 10 Bactericidal activity of released EM from PVA/Col/HA gels treated by 1, 2 and
3 F‐T cycles. A semiquantitative bacterial growth inhibition assay in broth treated
with medium containing released EM at predetermined time points. Control—the
initial OD of bacterial solution. n=3.
Viability and growth of MC3T3‐E1 cells
Live‐dead cell staining was utilized to study the cell viability of MC3T3 cells with
PVA/Col/HA gel after 7 days in culture, as shown in Fig. 11. The attachment and
proliferation of live MC3T3 cells (green) seeding on gel matrix can be visualized,
showing well the compatibility of the cell with the gel. However, the morphology of
cells growing on gels with different components and percentages of HA differed, and
cell density varied as well. Cells seeded on PVA gel showed less proliferation in
comparison with control cells. The addition of collagen and EM further reduced the
live cell amount. However, cells on PVA gel incorporating HA showed higher density
and well‐spreading morphology. In comparison, PVA gels with 7% and 10% of HA had
higher cell density and evenly‐spreading morphology than 4% and 15%. The addition
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of collagen and EM enhanced the cell attachment and proliferation as well. There were
only a few dead cells (red) observed, which indicated the cytocompatibility of prepared
gel matrices.

Fig. 11 The live (green) ‐dead (red) staining of MC3T3 cells cultured on PVA, PVA/Col,
PVA/Col/EM, PVA/Col/HA, PVA/Col/HA/EM, and PVA/HA with HA percentages of 4%,
7%, 10% or 15% for 7 days. Magnification: 100×.
To determine whether PVA/Col/HA hydrogel was cytotoxic, the LDH activity
released into the culture medium was measured. As shown in Fig. 12 (a, b), the LDH
activity in culture medium from F‐T hydrogel (C1, C3) treated cells is lower than that in
untreated cells (no gel coating), suggesting that PVA/Col/HA hydrogel provided a
“bone‐like” matrix for cell growth and reduced the number of apoptotic or dead cells
during cell culture. Since the intracellular LDH corresponded to the number of cells
in the culture, quantification of LDH activity in cell lysates can be used to measure cell
growth. As shown in Fig. 12 (c), an enhanced cell growth was found in hydrogel‐treated
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cells as compared to untreated cells. In addition, the incorporation of different
amounts of HA (4%, 7%, 10% and 15%) into PVA gels greatly enhanced the cell growth,
especially in the hydrogel with 10% HA incorporation.

The incorporation of Col and

EM showed little effect on cell growth. The enhanced cell growth on the PVA/Col/HA
hydrogel was further confirmed by the counts of total cell numbers 3 days after culture
(Fig. 12 (d)) and the MTT assay (Fig. 12 (e, f)).

Fig. 12 MC3T3 cell activity assay. LDH levels in culture medium from MC3T3 cells on
PVA/Col/HA gels after (a) 1 and (b) 3 cycles of F‐T treatment in 11 days, HA content=
10%. (c) LDH levels in cell lysate from MC3T3 cells on PVA/Col/HA gels with 4%, 7%,
10% and 15% of incorporated HA after culturing for 7 days. (d) Cell numbers
quantified from cells growing on PVA/Col/HA gels and well plate (control) during 72
hours of culturing, HA content= 10%. MTT assay results of MC3T3 cells on gels with
and without HA incorporation after (e) 3 days and (f) 7 days of culture, HA content=
10%. n=3, *p<0.05, **p<0.005.
ALP activity of MC3T3 cells
To determine the effects of PVA/Col/HA hydrogel on osteoblast differentiation,
intracellular ALP activity was measured. As shown in Fig. 13, a higher ALP activity was
found in cells cultured on hydrogels with F‐T treatment (C1 and C3) compared to
untreated cells.
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Fig. 13 Normalized ALP activities of MC3T3 cells cultured on PVA/Col/HA gels with 1
and 3 cycles of F‐T treatments. Control—cells cultured on well plate. n=3.
Viability and nitric oxide (NO) production of RAW 264.7 cells
As shown in Fig. 14 (a), there was no significant difference in the released LDH
activity in hydrogel‐treated cells as compared to untreated cells. The incorporation
of HA (0‐15%) in the PVA/Col gels had little effect on the released LDH activity.
Interestingly, the incorporation of EM resulted in a significant reduction (*p<0.05) of
released LDH activity in PVA/Col gels with both 10% and 15% of HA incorporation.
NO synthesis is increased in a various types of diseases and represents one of the
inflammation markers. An increase of NO production can be induced by
lipopolysaccharide (LPS) stimulated treatment of RAW 264.7 macrophages (Lee et al.,
2010). As compared to cells growing on HA incorporated gels, RAW cells cultured on
non‐HA incorporated gels had significantly higher NO production (Fig. 14 (b)). The
incorporation of HA showed a dose‐dependent reduction of NO production, and the
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incorporation of Col in the gels had a slight additional effect in reducing the NO
production. The addition of EM had no effect on NO production.

Fig. 14 LDH and NO assays for RAW 264.7 macrophage cells cultured with gels. (a)
LDH levels in cell lysate from RAW cells on PVA/HA, PVA/Col/HA and PVA/Col/HA/EM
gels with HA percentage of 4%, 7%, 10% and 15% for 14 days of culture. (b) NO
produced from activated RAW cells growing on PVA/HA, PVA/Col/HA and
PVA/Col/HA/EM gels with HA percentage of 4%, 7%, 10% and 15% for 14 days of
culture. n=3, *p<0.05.
Discussion

Failure of osseointegration (direct anchorage of an implant by bone formation at
the bone‐implant surface) represents one of the main causes leading to implant failure
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and loosening (Ramaswamy et al., 2009). Development of “bone‐like” implant surface
substitutes that are ‘‘intelligent” to enhance osseointegration is a clinical challenge.
We reported here a “bone‐like” PVA/Col/HA hydrogel composite that mimics the
biological, structural and mechanical behavior of natural bone. We found that
PVA/Col/HA gel provides a 3D scaffold matrix to increase preosteoblast cell adhesion,
proliferation, and differentiation. The PVA/Col/HA hydrogel composite also can be
used as a drug delivery device for a sustained and controllable release of antibiotics
(e.g., EM) and other drugs.
A bioactive implant surface can be created by the immobilization of biomolecules
into the implant surface coating matrix (de Jonge et al., 2008). Two approaches have
been reported to immobilize biomolecules onto coating matrix: (1) covalent
attachment to active surface groups, and (2) non‐covalent interactions by physical
adsorption (van der Waals, ionic bonds, hydrogen bonds, or hydrophobic interactions).
Physical adsorption, such as dip‐soaking method, is simple and can be performed
under mild conditions.

The limitations of dip‐soaking method include low coating

efficiency, burst release of embedded biomolecules and the impact of the solution’s
nature (pH, temperature and ion strength, etc.). Wahl et al. (Wahl and Czernuszka,
2006a) reviewed the most common routes for fabricating Col/HA composites and
found that the mechanical and biological properties of these Col/HA composites can
be improved by the modification of the collagen type, the cross‐linking methods, etc.
PVA, a highly water soluble polymer, was used to embed HA/Col/EM in the
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current study. It has been demonstrated that the encapsulated nano‐HA and collagen
can form hydrogen bonds with PVA molecules (Asran et al., 2010a). Matsumura et al.
(Matsumura et al., 2009) demonstrated that the incorporation of HA in the PVA gel
significantly enhanced the cell adhesion, differentiation and growth in a murine pre‐
osteoblast MC3T3‐E1 cell line. FTIR analysis showed that the inclusion of HA in the PVA
gel remarkably enhanced the material strength, lowered the swelling and resulted in
a longer drug release (Tang et al., 2009). A hydrogen bond interaction between PVA
and HA through their ‐OH groups leads to the development of mineralized structure
with functionalized surfaces and improved thermal properties. The unique
physiochemical features of the PVA/HA composite represent a promising formulation
for a wide variety of future applications in the field of bone regeneration. Our data
indicated that the PVA/Col/HA gels are not only “biomimetic” (structural, mechanical,
cellular and molecular), but also provides a sustained and controlled local EM release,
as these events are most significant to the orthopedic infection and bone defect. The
composite of Col and HA in the implant surface (Fan et al., 2005; Schliephake et al.,
2003) improves early bone ingrowth and behaved mechanically in a superior way than
the individual components. The ductile properties of Col increased the poor fracture
toughness of HA. The addition of Col to the HA structure provides additional
advantages, such as shape control, spatial adaptation, increased particle and defect
adhesion, and the capability to favor clot formation and stabilization (Wahl and
Czernuszka, 2006b).
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Fig.15 Illustration of gelation process of PVA‐HA‐Collagen hydrogel and cell
infiltration in gel matrix
A repeated freeze‐thawing (F‐T) treatment provided physical cross‐linking of the
PVA hydrogel by the intermolecular hydrogen bond formation (Hassan and Peppas,
2000b). Our results indicated the stiffness of gel increased as F‐T cycles increased.
Interpenetrating network structure of the denser PVA hydrogel provides an
extracellular matrix (ECM) like structure that promotes the cell adhesion, proliferation
and differentiation. In physiological conditions, ECM provides cells with topographical
features that trigger intracellular signaling cascades by interacting with the cells
through their transmembrane integrin receptors. The encapsulation of nano‐HA and
Col in the PVA gel provided numerous anchorage sites and appropriate mechanical
reinforcement for the cell adhesion and growth, as we observed (Figs. 5‐8). In addition,
PVA hydrogel is hydrophilic and biodegradable and has been used as one of the drug
delivery devices (Jensen et al., 2011). In this study, we embedded the EM into the
PVA/Col/HA gels and found that the physically cross‐linked PVA/Col/HA gels
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significantly extended the EM release and retained longer bactericidal activity.
This study has some limitations. First, PVA gel has a relatively weak adhesion
strength as compared to HA coating, and a paste of PVA gel coating might reduce the
porosity and interconnectivity beneath the implant’s HA coating. Although the PVA
coating is degradable after being put into a physiological environment, the potential
impacts of PVA coating‐induced reduction of pore porosity and pore interconnectivity
on cellular behaviors and bone ingrowths warrants further investigation. Second, we
need to determine whether the HA and Col has been dispersed evenly in the
capsulation of hydrophilic PVA gels, which might interfere with the biomimetic nature
of the PVA gel matrix and the cell behavior. Finally, the physiochemical properties and
optimal formulations of PVA/Col/HA gels need to be characterized in order to reach
the desired drug release profiles.

Conclusion

An implant surface PVA/Col/HA gel coating matrix was developed and
characterized. We found that the PVA/Col/HA gel provides a “bone‐like” extracelluar
matrix and its mechanical strength can be enhanced by repeated freeze‐thawing cycles.
PVA/Col/HA gel matrix is biocompatible and enhances the adhesion, growth and
differentiation of bone cells in vitro. In addition, PVA/Col/HA gel can serve as a
sustained drug release carrier to enhance osseointegration and prevent prosthesis
infection.
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CHAPTER 4 MONOLITHIC ELECTROSPUN NANOFIBERS
Introduction
Natural bone is composed of a complex hierarchical structure with mineralized
collagen fibrils and HA nanocrystals (Stanishevsky et al., 2008). The organic matrix is
mainly Type I Collagen (Col) which provides bone its flexibility and resilience, and is
important for cell adhesion and migration (Stanishevsky et al., 2008). The inorganic
phase is composed of mineral hydroxyapatite (HA) which is responsible for the
stiffness and strength of bone. Nano scale‐HA crystals are crucial for osteoinduction,
biomineralization and osteointegration (Wei and Ma, 2004). The organic–inorganic
constituents combine together to provide a mechanical and supportive role in the
body (Pramanik et al., 2009).

Osseointegration is defined as the direct anchorage of

an implant by bone formation at the bone‐implant surface. Many research efforts
have been directed towards improving the bone/implant interface, with the aim of
accelerating bone healing and improving bone anchorage to the implant (Park, 2011;
Gittens et al., 2011; Hermida et al., 2010; Junker et al., 2009; de Jonge et al., 2008;
Borsari et al., 2007; Perla and Webster, 2005). One of many research strategies is to
develop a biopolymer‐based implant surface with “bone‐like” nature (structural,
mechanical, and

biological behavior ) (Omar et al., 2010; Zhang et al., 2010; Tan et

al., 2006; De et al., 2004). HA composites with biodegradable polymers, such as poly
lactide (PLA) or poly (lactide‐co‐glycolide) (PLGA) (Kim et al., 2006b), were fabricated
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to reduce the implant surface fragility. However, unfavorable effects of acidic
degradation products (lactic and glycolic acid) from these polymers on the cells
surrounding the implants have become a concern (Estey et al., 2006; Fu et al., 2000).
Polyvinyl alcohol (PVA), a water‐soluble and biodegradable polymer, has been used
extensively in the pharmaceutical industry because of its biocompatibility, proven
mechanical strength and anabolic effect on bone formation (So et al., 2007;
Matsumura et al., 2009; Ngawhirunpat et al., 2009; Sailaja et al., 2009). In addition,
PVA has self‐crosslink capability (film or hydrogel forming) due to the abundant
number of hydroxyl groups in their side chains (So et al., 2007; Matsumura et al., 2009;
Ngawhirunpat et al., 2009; Sailaja et al., 2009).

Fig. 16 Illustration of electrospining nanofibers set‐up and mechanism of fiber
formation
Nanoscale topography of implant surface is critical for the capacity of
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osseointegration (Gittens et al., 2011; Mendonca et al., 2009; Dalby et al., 2006).
Different topographies, methods and materials have been developed to enhance
osseointegration (Dohan Ehrenfest et al., 2010; Tomisa et al., 2011; Gittens et al., 2011;
Dohan Ehrenfest et al., 2010; Huang et al., 2008).

One alternative approach has been

the electrospun nanofibers (Prabhakaran et al., 2009; Asran et al., 2010b; Francis et al.,
2010; Schofer et al., 2008). Electrospinning is a process in which a charged polymer
jet is collected on a grounded collector; a rapidly rotating collector results in aligned
nanofibers while stationary collectors result in randomly oriented fiber mats, as shown
in Fig.16.

Electrospinning forms superfine fibers with diameters ranging from 10 μm

down to 10 nm by forcing a polymer solution with an electric field through a spinneret
(Torres‐Giner et al., 2009). The advantages of electrospun nanofibers over
conventional film‐casting techniques include a high surface area, high mass to volume
ratio and a small inter‐fibrous pore size with high porosity (Ifkovits et al., 2009). These
features make electrospun polymeric fibers excellent candidates for fabrication of
implant surfaces and for controlled periprosthetic drug delivery (Kim et al., 2008;
Sargeant et al., 2008; Asran et al., 2010b; Cho et al., 2009; Ekaputra et al., 2009).
Organic solvents or acids are usually required to dissolve either synthetic (PLGA and
PLA, etc) or natural (chitosan, gelatin, collagen, etc.) polymers (Duan et al., 2007;
Yoshimoto et al., 2003; Huang et al., 2001; Shin et al., 2001; Zhou et al., 2008)
to electrospinning (Huang et al., 2003).

prior

PVA is a water‐soluble and has better

nanofiber forming capability (Wu et al., 2005; Zhou et al., 2008), in part due to its
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sufficiency in electroconductivity (Kenawy et al., 2003; Wu et al., 2005). However,
the limitation of PVA nanofibers are obvious, including fast hydrolysis (Yao et al., 2003),
and its bioinert nature (Asran et al., 2010a) that hinder the protein and cell adhesion
(Schmedlen et al., 2002). Thus, additional efforts are required to incorporate nano HA
particles and collagen into PVA nanofibers to mimic natural extracellular bone matrix.
Followed by the idea from previous chapter, we developed a biomimetic
nanofiber scaffolds consisting of PVA‐Collagen with unidirectionally aligned nano HA
particles. The physiochemical properties and degradation profiles have been described.
In addition, the behavior of murine osteoblastic MC3T3 cells (adhesion, proliferation
and differentiation) growth on the PVA‐Col‐HA nanofiber scaffolds was examined.

Materials and Methods

Materials
Nano‐Hydroxyapatite (HA) (Avg. 20‐70 nm, specific surface area: 110 m2/g,
density: 3.0 g/mL) (Berkeley Advanced Biomaterials, INC., Berkeley, CA),

Polyvinyl

Alcohol (PVA, Mw~205,000, 86.7‐88.7 mol% Hydrolysis, 4200~ Polymerization),
Albumin fluorescein isothiocyanate conjugate bovine (Albumin‐FITC, >7 % mol FITC
albumin), Collagen Type I (from rat tail, in 5 wt% acetic acid) (Sigma‐Aldrich, St. Louis,
MO), Ultrapure water (DNAse, RNAse Free, 0.1 micron filtered) (Invitrogen Corp.,
Grand Island, NY), Murine MC3T3‐E1 preosteoblasts (ATCC, Manassas, VA), α‐modified
minimum essential medium (α‐MEM) (Invitrogen, Carlsbad, CA), Alkaline phosphatase
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(ALP)

assay

kit

(ATCC,

Manassas,

VA),

3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐

diphenyltetrazolium bromide (MTT) assay kit (ATCC, Manassas, VA).
Electrospinning of PVA‐Col‐HA nanofibers
PVA was dissolved in ultrapure water at 90 ºC (10 %, w/v, g/mL). The emulsified
solution of HA nanoparticles was added to PVA solution and homogenized at 60 ºC by
various HA/PVA ratio (HA/PVA=1/2, 1/4, 1/9, v/v). Albumin FITC was firstly dissolved
in ultrapure water (0.1 mg/mL) and then thoroughly mixed with cooled HA‐PVA slurry
(Albumin, 10 %, v/v) for 10 min. Collagen solution (acetic acid, 5 wt %) was then
homogenized with the mixture to finalize the PVA‐Col‐HA‐Albumin FITC blend (Col,
10 %, v/v). The suspension of the blend was immediately loaded in a syringe (5 mL, B‐
D Scientific, Franklin lakes, NJ) connected to a high purity tubing (IDEX Health and
Science, Oak Harbor, WA) with a 26 G1/2 needle (B‐D Scientific, Franklin lakes, NJ) with
blunted tip (0.6 mm inner diameter). The syringe was attached to a syringe pump (R‐
100E, Razel Scientific Instruments, St. Albans, VT) with a setting flow rate (Q). A high
voltage power supplier (ES40P, Gamma High Voltage research, INC., Ormond Beach, FL)
was connected to the needle. The electrospinning settings parameters were as follow:
Voltage=18 kV, Q=7.8 μL/min, needle tip‐to‐collector distance=10 cm. A rotational
speed of 500 rpm was used to evenly deposit the solute on glass coverslips attached
to the stainless steel hexahedron collector linked to the shaft of a motorized stirrer
(JR4000, Arrow Engineering Co, INC., Hillside, NJ).. Electrospinning was running in dark
for 1 hour to collect fibers. Samples were dried overnight (O/N) before testing.
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Characterizations of PVA‐Col‐HA nanofibers
Scanning electron microscope (SEM)
PVA‐Col‐HA nanofibers deposited on coverslips were gold‐coated (Gold Sputter,
Effa Coater, USA) and the morphology of the nanofibers was characterized by Scanning
electron microscope (SEM) (JSM‐6510LV‐LGS, MA, USA). The distribution of fiber
diameter was measured from the SEM images using analysis software (Image J,
National Institute of Health, USA).
Transmission Electron Microscope (TEM)
The encapsulation of HA nanoparticles in individual fibers was determined by
Transmission Electron Microscope (TEM) (JEOL‐2010 FasTEM, USA). TEM samples were
prepared by directly depositing nanofibers onto Cu‐grids covered with ultrathin carbon
layers. Dispersive X‐Ray spectrometry (EDAX) was used to analyze the chemical
composition in area of sample surface of interest.
Optical Microscope
Images of nanofibers were also recorded under 10 × and 40 × through both visible
light and fluorescence by an optical microscope (HAL 100, Carl Zeiss Microimaging,
INC., Thornwood, NY), supplemented with microscope light source system (X‐cite
series 120Q, Lumin Dynamics Group Inc., Mississauga, Canada).
The intensity of fluorescence from albumin‐FITC incorporated into nanofibers was
also quantified by reading the deposited coverslips with the excitation/emission
wavelength of 485/528 nm in a UV/VIS Spectrophotometer (BioTek Synergy HT, USA).
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Total 9×9 counts were measured to calculate the mean relative fluorescence unit (RFU).
Contact Angle
The sessile drop method was used to measure the contact angle of coverslips
surface with deposited nanofibers at ambient temperature. Three 10 μL droplets of
distilled water were placed on the different spots of converslips surface until
equilibrium and contact angles were measured by a Contact Angle Goniometer (Ramé‐
Hart, USA) to calculate the mean value.
Atomic Force Microscopy (AFM)
We characterized the surface morphology of nanofibers using a Multimode IIIa
AFM (Digital Instruments) and a Dimension 3100 AFM (VEECO). AFM imaging of the
nanofibers were conducted using Contact Mode in air. Positioning within micrometer
accuracy of the cantilever on top of the nanofibers is achieved by the integrated optical
microscope. The data were collected by mapping the fibers within a 20×20 μm2 sized
grid.
The nanomechanical properties of the nanofibers can be studied by AFM force‐
versus‐distance curves in Contact Force Calibration Mode (Blacklock et al., 2010;
Mermut et al., 2003). The calculation was done by analyzing data collected on more
than 20 spots using 6 specimens. The force curves were fitted to the Hertz model and
Hooke’s law was used to calculate the loading force (F). The nanofibers have a much
larger radius of curvature than the AFM tip (~ 20 nm) and can be treated as a planar
surface. The measured elastic modulus (E) is qualitatively related to Young’s modulus.
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Rheology Characterization of nanofiber precursor solutions
An AR2000 rheometer (TA Instruments Inc., New Castle, DL) with a standard steel
parallel‐plate geometry of 20 mm diameter was used for the rheological
characterization of all precursor solutions. Test methods of oscillatory stress sweep
and frequency sweep were employed. The stress sweep was holding the temperature
(25°C) and frequency (2π rad/s) constant while increasing the stress level from 0.001
to 10 Pa. The linear viscoelastic region (LVR) from 0.001 to 10 Pa were determined as
safe‐region without structural breakage from oscillatory stress. Samples were
subjected to a steady stress ramp and the corresponding storage modulus (G’) and loss
modulus (G”) were measured. The frequency sweep was performed at a fixed stress
corresponding to the point in the middle of the LVR profile. The oscillatory frequency
was increased from 0.1 to 100 rad/s, and the plots of G’ and G” toward frequency were
obtained from manufacture provided software. Complex viscosity (η*) and the tangent
of the phase angle (tanδ) (ratio of G”/G’) were obtained from a flow test to plot against
frequency as well.
Degradation of PVA‐Col‐HA nanofibers
The PVA‐Col‐HA nanofibers deposited on coverslips were subjected to in vitro
degradation study at 37 ºC. Briefly, the coverslips were placed into 12‐well plate and
immersed by ultrapure water in incubator for 236 h. Morphology of nanofibers after
water‐immersion was timely characterized by optical microscope and SEM.
Cell culture
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MC3T3 cells were seeded on the coverslips deposited with electrospun fibers.
Briefly, coverslips were placed into 12‐wells cell‐culturing plate. Murine MC3T3‐E1
preosteoblasts (ATCC, Manassas, VA) were cultured in α‐modified minimum essential
medium (α‐MEM, Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine
serum (Invitrogen, Carlsbad, CA), 10 mM β‐Glycerophosphate (Sigma, American), and
1 % (v/v) antibiotics mixture of penicillin and streptomycin at 37 ºC in a humidified
incubator with 5 % CO2. MC3T3‐E1 cells were plated at a density of 1×104 cells/ well
(12‐well plate) onto placed coverslips surfaces with deposited nanofibers.
Cell attachment and proliferation
The mitochondria activities of MC3T3 cells culturing with nanofibers after 48 h
and 72 h were determined by colorimetric assay which detected the conversion of 3‐
(4,5‐dimethylthiazol‐2yl) ‐2,5‐diphenyltetrazolium bromide (MTT) (ATCC, Manassas,
VA) to formazan. 20 μL/well of MTT solution (1 mg/ml in test medium) was added and
the wells were incubated at 37 ºC for 4 h to allow the formation of formazan crystals.
Then the dimethylsulfoxide (DMSO) (100 μL/well) was added to all wells and mixed
thoroughly to dissolve the dark blue crystals. The optical density (OD) of extracted
medium was measured in a UV/VIS Spectrophotometer (BioTek Synergy HT, U.S.A.) at
490 nm.
Cell viability was also evaluated using the LIVE/DEAD® Viability/Cytotoxicity
staining kit (Invitrogen Corp., Grand Island, NY). Viable cells fluoresce green through
the reaction of calcein AM with intracellular esterase, whereas non‐viable cells
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fluoresce red due to the diffusion of ethidium homodimer across damaged cell
membranes and binding with nucleic acids. The cells‐nanofibers interaction was
visualized under fluorescence microscope (Carl Zeiss microimaging, USA) and AFM
(Digital Instruments Nanoscope IIIA, USA).
For the cell differentiation experiment, MC3T3 cells were cultured in
osteogenic media (regular media described above plus 10 mM ‐glycerophosphate
and 50 μg/ml L‐ascorbic acid (Sigma)) before they were harvested at 9 d. Culture
media were changed every three days. The alkaline phosphatase (ALP) activity of
MC3T3 cells after treating with differentiation medium was measured by commercial
kit (ATCC, Manassas, VA). 80 μL ALP buffer was added and the plate was incubated at
4 ºC for 4 h. The cell lysate was then centrifuged at a speed of 13,000 g for 3 min and
cell debris was discarded. 50 μL of p‐nitrophenyl phosphate (pNPP) was added to react
with cell lysate for 60 min in dark at room temperature. 20 μL stop solution was then
added to terminate the ALP activity. The standard curve was drawn by using pNPP of
0, 4, 8, 12, 16, 20 nmol/well to react with 10 μL of ALP enzyme solution. The O.D. was
measured at 405 nm.

Statistical analysis
Data were analyzed with SPSS Version 12.0 (SPSS, chicago, IL). All values are
expressed as mean standard deviation. Analysis of variance (ANOVA) was used to
analyze the experimental data from all the experiments. Statistical significance was set
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to p < 0.05.
Results

Optical microscopy of PVA‐Col‐HA nanofibers
In this study, emulsion of HA nanoparticles was homogenized with PVA solution
(10 %, w/v) at various ratio of 1/2, 1/4 and 1/9 (v/v). Randomly oriented electrospun
fibers are visualized in Fig.1. Micro‐beads can be observed from HA/PVA (1/2)
nanofibers, as shown in Fig.1 (a), which were caused by the failure of fiber‐formation
during spinning. Apparently, excessive amount (HA/PVA=1/2) of incorporated nano‐
HA disturbed the homogeneity of PVA solution and the stability of electrospinning. In
comparison, fibers mesh fabricated from PVA‐Col‐HA precursor solution with lower
amount of nano‐HA (1/4 and 1/9) was thicker and more homogenous, as shown in
Fig.17, (c, e). The presence of Albumin FITC coupling with HA nanoparticles was
visualized in electrospun fibers.(Hlady and Furedimilhofer, 1979; Wassell et al., 1995).
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Fig.17 (a) light‐visible images of PVA‐Col‐HA nanofibers with PVA/HA ratio of 2:1, 4:1
and 9:1 (v/v). (b) Fluorescence images of the same nanofibers when excited with
blue light. Images were observed under 10× and 40× objectives, respectively.
Electron microscopy of PVA‐Col‐HA nanofibers
The encapsulation of nano‐HA in nanofibers was characterized by TEM (Fig.18).
The rod‐like HA particles were mostly oriented along the axial direction inside
individual fiber, whereas a few were perpendicular to the axial direction extruding the
fiber. Rough surface caused by these extrusions could provide anchorage sites for cell
adhesion during tissue regeneration (Asran et al., 2010a). The elemental composition
of nanofibers determined by EDAX reveals the Ca‐P components encapsulated within
fibers. The morphology of fiber structure was also characterized by SEM (Fig.19 and
20). Large amount of Ca was quantified at the extrusion spots on nanofibers surface.
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It is showed that precursor solutions at all HA/PVA ratios (1/2, 1/4 and 1/9) were
capable to fabricate fiberous meshes through electrospinning (Fig.19 and 20). The
inclusion of collagen during electrospinning showed no effects on fiber formation. The
average diameters of fibers without collagen were similar (508, 484 and 514 nm) at
different HA/PVA ratios (Fig.3), while the average diameters of fibers with collagen
dropped (552, 416 and 362 nm) followed by the decrease of HA/PVA ratio (Fig.20).

Fig.18 Representative TEM micrograph of PVA‐Col‐HA nanofibers with PVA/HA ratio
of 4:1 (upper panels). Elemental composition of nanofibers obtained from EDAX
(bottom panel).
Atomic force microscopy (AFM) of PVA‐Col‐HA nanofibers
We used AFM to study the morphology and mechanical property of single strand
fiber with different ratio of HA/PVA via contact‐force model. The tip is kept at a close
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distance to the sample surface by a feedback mechanism to return height and
deflection images from scanning area. Rough surface of nanofibers was observed from
height images as expected as the extrusion of encapsulated HA nanorods (Fig.21 (A)
and (B)). Fiber surface turned smoother in consistent with reduced encapsulation of
HA.
The obtained Young’s modulus (E) of nanofibers with encapsulated HA was higher
than the pure PVA nanofibers (0.826 MPa), which revealed the increment of the fiber
stiffness. E significantly increased when higher amount of HA was encapsulated into
nanofibers (HA/PVA=1/2) (Fig.21 (C)) compared to others (1/4 and 1/9). The
incorporation of collagen showed less influence on the stiffness of nanofibers.

Fig.19 SEM micrograph of PVA‐HA nanofibers with PVA/HA ratio of 2:1, 4:1 and 9:1
(upper panel: 1000×; middle panel: 10000×). The diameter histogram of
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corresponded nanofibers analyzed from 1000× micrographs (bottom panel).

Fig.20 SEM micrograph of PVA‐Col‐HA nanofibers with PVA/HA ratio of 2:1, 4:1 and
9:1 (upper panel: 1000×; middle panel: 10000×). The diameter histogram of
corresponded nanofibers analyzed from 1000× micrographs (bottom panel).
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Fig.21 AFM contact mode images of (A) PVA‐HA and (B) PVA‐Col‐HA nanofibers with
PVA/HA ratio of 2:1, 4:1 and 9:1 (upper panel: height images; middle panel:
deflection images). (C) The mean Young’s modulus (E) of single nanofibers (n=6)
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Hydrolytic degradation of PVA‐Col‐HA nanofibers
In this study, all PVA‐Col‐HA nanofibers were prepared at the same condition with
various ratios of HA/PVA. PVA shows high efficiency in electrospinning for its strong
hydrophilicity but high dissolution rate in aqueous solution (Yao et al., 2003). We
attempted to incorporate HA nanoparticles to reinforce the mechanical strength and
hydrophobicity of PVA nanofibers. Nanofibers with different HA/PVA ratios (1/2, 1/4
and 1/9) were immersed in ultrapure water and timely observed by fluorescence
microscope (Fig.22) and SEM (Fig.23, (A)). Within 2h of soaking, the fluorescence
intensity of 1/9 nanofibers was low while others were still intense (Fig.6). The
fluorescence of nanofibers was gradually decayed following by long‐term soaking (48
h and 236 h). The fluorescence of 1/4 nanofibers was most durable, and the mesh
structure of 1/4 nanofibers was still observable after 236 h soaking.
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Fig.22 (a) The fluorescence images (10×) of PVA‐Col‐HA nanofibers with PVA/HA ratio
of 2:1, 4:1 and 9:1 soaking in 37ºC water for 2h (upper panel), 48h (middle panel)
and 236h (bottom panel). (b) The change of fluorescence intensity for nanofibers
during soaking.
The morphologic change of individual fiber after soaking can be visualized in SEM
micrograph (Fig.23, (A)). After 48 h of soaking, the fiber structure of 1/2 and 1/4
nanofibers retained (Fig.23, (A)) while 1/9 nanofibers were mostly failed. Precipitates
observed around fibers were released HA nanoparticles from nanofibers during
degradation. After 236 h of soaking, polymeric components of fibers were mostly
degraded, and the encapsulated HA nanoparticles lined along fiber axis.
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Fig.23 (A) SEM micrograph (10000×) of PVA‐Col‐HA nanofibers with PVA/HA ratio of
2:1(left) and 4:1(right) soaking in 37ºC water for 48h (upper panel) and 236h (bottom
panel); (B) Contact angles of PVA‐HA (red) and PVA‐Col‐HA (black) nanofibers with
PVA/HA ratio of 2:1, 4:1 and 9:1. (Control: glass coverslips without nanofibers)
Contact angle of PVA‐Col‐HA nanofibers
The nano‐scaled roughness on substrate surface could alter the hydrophilicity of
materials. In this study, encapsulated HA nanoparticles were expected to influence the
hydrophilicity of PVA fiber mesh. The contact angles (θ) for these nanofiber meshes
(1/2, 1/4 and 1/9) were measured to reveal the hydrophilicity (Fig.23, (B)). Generally,
the contact angle decreases when the amount of HA encapsulation is smaller for
nanofibers with or without collagen. Fibers with collagen have larger θ than fibers
without collagen might due to its peptide strands. This result indicated that
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encapsulated HA nanorods enhanced the hydrophobicity of PVA nanofibers.

Fig.24 (a) Storage modulus (G’) and loss modulus (G’’) profiles across a oscillatory
range of 0.001–10 Pa at 25°C; (b) complex viscosity, (c) tan delta, (d) Storage
modulus (G’) and (e) loss modulus (G’’) profiles across a frequency range of 0.1–10
rad/s at 25°C for PVA‐HA and PVA‐Col‐HA precursor solution (PVA:HA=9:1, 4:1 and
2:1)
Rheological properties of PVA‐Col‐HA nanofibers precursor solution
The predominance of G’’ over G’ in all precursor solutions can be observed from
oscillation stress sweep for the applied non‐destructive stress range (Fig.24, (a)), which
indicated the prevalence of viscous fluid behaviors for precursor solution in a sol state.
The gradual decrease of G’’ followed by the increase of incorporated HA amount
showed the influence of HA on rheological property of precursor solutions (Fig.24, (a)).
The Col content seemed to minimize the G” that might indicate its interaction with
other molecules (Fig.24, (a)). An increase in both G’ and G’’ as the frequency increased
was revealed (Fig.24, (c) and (d)). All G’’ (1‐100 Pa) are dominant over G’ (0.1‐10 Pa)
and the decrease of G’ slope according to the increase of incorporated HA revealed
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the weakly structured system. The complex viscosities (η*) of all solutions were
decreasing across the frequency range suggesting pseudoplastic behaviour (Fig.8, (b)).
It is noted that the slope of η* curve across the frequency range was flattened followed
by the decrease of incorporated HA in system (except 1/2 No‐Col). This result
suggested more bonding interactions were formed by more incorporated HA with PVA,
and the dismantling of HA‐PVA linkage leaded by higher frequency of shear stress was
more significantly revealed by the decrease of η*. As tan δ is a ratio of G’’ to G’, a value
above 1 indicates a material with dominant liquid‐like behavior and a value below 1
indicates a material with dominant elastic (solid‐like) behavior (Tanna et al., 2006). All
curves of tan δ were above 1 indicated the liquid state of precursor solution. However,
the addition of nano‐HA seemed to assist the transition from sol to gel, as the tan δ
curve of solution with higher HA content was gradually fell and closely approaching to
1 in lower frequency (except 1/2 No‐Col) (Fig.24, (c)). Taken together, the incorporated
HA was capable to modify the viscoelasticity of precursor solution by interacting with
PVA.
Cell behavior culturing on PVA‐Col‐HA nanofibers
Live‐dead cell staining was utilized to study the cell morphology and interaction
with nanofibers after 72 h culturing (Fig.25, (a) and (b)). The attachment and
proliferation of live MC3T3 cells (green) seeding on nanofibers mesh can be visualized,
showing well compatibility of cell‐fibers. Cells grown on both 1/2 and 1/4 nanofibers
(Fig.25, (a) and (b)) had much better adhesion and cell spreading pattern, compare to
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the cells grown on 1/9 nanofibers after 72 h culturing. No obvious dead cells (red) were
observed in all cell colonies seeding on nanofibers with and without collagen.
Nevertheless, cells on 1/9 nanofibers were less spread, which is probably due to the
earlier failure of the supporting fiber‐mesh.
The MTT result from 8 d of culturing was quite consistent with the live‐dead
staining (Fig.25, (c)). Cells seeded on all groups of nanofibers showed significantly
higher proliferation rate than cells seeded on coverslips without nanofibers (Control).
It indicated the nano‐fibrous mesh promoted the spread and proliferation of
osteoblastic cells. The incorporation of collagen can further benefit the cell
proliferation along nanofibers, as shown as the higher proliferation rate in MTT results
(Fig.25, (c)). The sudden decrease of cell proliferation on 1/9 nanofiber with collagen
might be attributed to cell detachment from failed PVA‐Collagen fibers. 1/4 nanofiber
with collagen was revealed to be most durable and interconnective for cell adhesion
and prolifereation, verified by both in live‐dead images and MTT results (Fig.25, (a) (b)
and (c)). Moreover, the ALP levels normalized with protein levels were measured for
each cell groups to analyze the influence of nanofibers on cell functionality (Fig.25, (d)).
The results showed that there was no significant difference among cells culturing on
different nanofibers. In sum, the nanofibers promote osteoblastic cells adhesion and
proliferation without influencing the cell functionality. The cell proliferation rate on
nanofibers was dependent on the durability of nanofibers. The interaction of cell‐
nanofibers was further characterized by AFM via contact mode. Cells were interact
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with surrounding fibers and infiltrate into the fibrous mesh to form a sandwich mode.

Fig.25 MC‐3T3 cell activity assay. The live (green) ‐dead (red) staining (a, b;
objectives, 10× and 40×) of MC3T3 cells cultured on PVA‐HA (a) and PVA‐Col‐HA (b)
nanofibers mesh for 72h. MTT results (c) of cells cultured on HA‐PVA‐albumin FITC
(white column) and PVA‐Col‐HA (black column) nanofibers for 8d. Normalized ALP
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activity of cells cultured on PVA‐HA (white column) and PVA‐Col‐HA (black column)
nanofibers for 8d. (Control: glass coverslips without nanofibers). (**p<0.005, n=3)
Discussion

Failure of osseointegration (direct anchorage of an implant by bone formation
at the bone‐implant surface) represents one of the main causes leading to implant
failure and loosening(Ramaswamy et al., 2009). One of the important challenges in the
field of implant surface fabrication is the development of “bone‐like” implant surface
substitutes that are ‘‘intelligent” to instruct the in vivo environment to form bone. We
propose that a “bone‐like” nanofibers implant surface coating mimics the biological,
structural and mechanical behavior of natural bone, and enhances the adhesion,
growth and differentiation of surrounding bone marrow stromal cells. To imitate the
architecture of the natural bone matrix, we developed electrospun PVA nanofibers
with embedding of nanoscale HA and type I collagen (Col). We found that 15 % PVA
mixed with HA (10 %) and Col (10 %) provides a better cellular response (adhesion,
proliferation and differentiation), defined degradation pattern (Fig.22 and 23), and
favorable surface roughness as well as mechanical strength (Fig.19‐21) with
characterized physiochemical properties (Fig.21 and 23). PVA‐Col‐HA nanofibers were
prepared using empirical combinations of electrospinning variables. Several distinct
morphologies were observed including fiber diameter distribution, surface roughness,
alignment, orientation of nano HAs in the fibers, etc. (Fig. 19‐24)
PVA has recently been applied as electrospun nanofibers for its hydrophilicity
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and high electroconductivity ensuring its feasibility of spinning. Nevertheless, the
rapid hydrolysis rate limits the application of PVA electrospun nanofibers as stable and
reliable tissue scaffolds. The attempts to modify the hydrophilicity of PVA nanofibers
are numerous. Y. Li, et al.(Yao et al., 2003) stabilized PVA nanofibers in water by
methanol treatment to increase the crystallinity of PVA. T. Pisuchpen, et al.(Pisuchpen
et al., 2011) enhanced the rigidity and hydrophobicity of PVA nanofibers via the
addition of silica. L. Feng and L. Jiang(Feng et al., 2003) showed the highly aligned PVA
nanofibers possessed superhydrophobicity attributed to the reorientation of PVA
molecules. All of these studies indicate the amphiphilic PVA is chemical amendable in
inherent.
The hydrophilic phenomenon of PVA contacting with water is acknowledged
as the excessive exposure of hydrophilic hydroxyl groups (‐OH) to water molecules and
hence the hydrogen‐bonding interactions. Hydrophobic alkyl groups (‐CH‐) as the
backbone of PVA are repelled by H2O molecules to interior(Hassan and Peppas, 2000a).
The initial swelling stage of PVA in water can be considered as the process of
conformational reorientation for PVA molecules. While the later dissolving stage is the
stabilization of reoriented PVA molecules in water phase. In native, ‐CH‐ and –OH
groups are evenly distributed around PVA surface. However, in certain circumstances,
the arrangement of ‐CH‐ groups to be dominant on PVA surface with lower free surface
energy could dramatically alter its original hydrophilicity in water(Feng et al., 2003).
It has been demonstrated the encapsulated nano‐HA and collagen in PVA
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nanofibers would form hydrogen bonds with PVA molecules, which significantly
changed the crystallinity of PVA (Asran et al., 2010a). The hydrogen bonding in blend
system can also be demonstrated from the rheological characterization (Fig.24). Our
results indicated that the PVA‐Col‐HA precursor solutions were in viscous sol‐like state
that is capable to be electrospun. The interaction of embedded nano‐HA and collagen
with PVA might result in reduction of free –OH groups while augment of ‐CH‐ groups
on nanofiber surface, and subsequently affect the wettability of nanofibers. Our study
demonstrated the water repelling effect of nanofibers attributed to nano‐HA
incorporation was increased regarding to the HA ratio (from HA/PVA=1/9 to 1/2), as
shown in contact angle results (Fig.23, (B)). More gradual change and larger contact
angles could be revealed from nanofibers consisted collagen, which also confirmed the
hydrogen‐ bonding interaction of collagen‐PVA. From aspect of nanostructured
surface‐interface theory (Cassie‐Baxter model), rough surface allows air to be trapped
between the liquid and the underlying solid surface and repel the water(Pisuchpen et
al., 2011). In present study, the encapsulation of HA nanorods within the nanofibers
were identified to increase the surface roughness (Fig.19‐21). The contact angle of HA‐
PVA nanofiber surface was increased probably due to the hydrophobic pockets located
on the interface.
The promotion of hydrolytic resistance enabled the supportive role of nanofibers
allowing the cell infiltration and migration. Studies have been shown cellular growth
and functions can be regulated by nanofibers parameters, such as alignment, pore
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geometry, surface area, etc. In physiological conditions, ECM fibers provide cells with
topographical features that trigger morphogenesis by interact with the cells through
their transmembrane integrin receptors to initiate intracellular signaling cascades (Kim
et al., 2010; Hynes, 2009). Nanofibers prepared as bone scaffolds revealed to be
interacted with bone cells and guided the mineralization(Yoshimoto et al., 2003). We
proposed that the encapsulated nano‐HA and collagen provided anchorage sites for
cell adhesion and mechanically enforced nanofibers to support cells. The interaction
of cell‐nanofibers can be visualized via cell stainings (Fig.25)
One of the potential applications of this nanofibers scaffold is to provide a
“bone‐like” implant surface coating to enhance osseointegration by allowing the
recruitment of bone marrow osteoblastic cells into the scaffold matrix. But there are
some limitations need to be addressed for this study. The efficiency of electrospinning
was estimated to be interrupted by adding HA nanoparticles and collagen to PVA
precursor solution. Parameters of the precursor solution for electrospinning, such as
viscosity, molecular weight, electroconductivity, etc., could dramatically influence the
generation of nanofibers. Further investigations on some decisive parameters
corresponding with HA and collagen ratio need to be performed in the future.
Moreover, the incorporation of HA and collagen extended the degradation of PVA
nanofibers to about 10 days. But more durable fibers applied as biomimic tissue‐
engineering scaffolds could be further‐stablized by cross‐linking approaches, such as
UV treatment, freeze‐thawing, etc., and exploration on tunable degradability of
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nanofibers need to be elaborated in the future.
Conclusion

PVA‐Col‐HA nanofibers fabricated by electrospinning revealed excellent
biodegradability, biocompatibility and bioactivity. The mechanical strength and
hydrolysis resistance of nanofiber are reinforced by incorporation of HA nanoparticles
and collagen. The nanofibers enhanced the adhesion and proliferation of interacted
bone cells. We propose PVA‐Col‐HA nanofibers might be promising biomimetic
materials modifying the implant surface for orthopedic applications.
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CHAPTER 5 COAXIAL‐NANOFIBERS FOR SUSTAINED DRUG RELEASE
Introduction

An early and rapid osseointegration requires the recruitment of bone marrow
stromal cells (BMSCs) to the periprosthetic site (Lee and Goodman, 2008). After
surgery, the gap between the implant surface and surrounding bone needs to be
completely bridged by newly formed bone. There is compelling evidence that a
defective implant osseointegration (the formation of a piece of fibrous membrane
between the implant surface and surrounding bone) leads to implant instability,
micromotion, osteolysis and loosening (White et al., 2012a).

Kärrholm et al.

(Karrholm et al., 1994) reported that the subsidence of the implant is associated with
an increased risk of AL.

Ryd et al. (Ryd, 1992) proposed that the occurrence of

implant instability and micromotion represent two of the risk factors of early implant
loosening in both knees and hips. The rate, quantity and quality of osseointegration
are closely related to the physiochemical and biological properties of the implant
surface (de Jonge et al., 2008). More efforts are required to develop a “bone like”
implant surface that shows potential for implant osseointegration.
Natural bone is an organ composed of a complex hierarchical structure with the
organic–inorganic constituents combine together (de Jonge et al., 2008). Many implant
surface fabrication techniques have been developed with the aim of improving
osseointegration (Anselme et al., 2010; Ponche et al., 2010). However, current clinical
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studies found no significant improvement in clinical outcomes in patients with a
cementless hip replacement as compared to those with a cemented hip replacement
(Steens et al., 2010; Yamada et al., 2009). The limitations of HA coating includes (1) a
non‐physiological surface leads to diminished initial osseointegration (Goosen et al.,
2009; Chung et al., 2008); (2) brittle nature (Song et al., 2010a; Leeuwenburgh et al.,
2006); (3) poor adhesion strength (Heimann, 1999; de Jonge et al., 2008) and (4) the
lack of controllable drug release (Zhang et al., 2004). Current studies demonstrated
that the nanoscale topography of the implant surface is critical for earlier
osseointegration (Gittens et al., 2011; Dalby et al., 2006) and sustained drug release
(Su et al., 2012a).
One of the promising technologies to mimic bone nanoscale extracellular matrix
(ECM) structure is electrospinning. Electrospinning forms superfine fibers with
diameters ranging from 10 μm down to 10 nm by forcing a polymer solution with an
electric field through a spinneret (Baker et al., 2009). A rapidly rotating collector results
in aligned NFs while a stationary collector results in randomly oriented NF mats. The
advantages of electrospun NFs include a high surface area, high mass to volume ratio
and a small inter‐fibrous pore size with high porosity (Sundararaghavan et al., 2010).
The potential application of electrospun NFs for the enhancement of osseointegration
is promising but obviously overlooked. It was demonstrated that the NF structural cues
alone can be used to create an osteogenic environment without the use of exogenous
factors (Wang et al., 2012). The cell attachment, proliferation, and differentiation of
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osteoblastic cells in vitro are significantly influenced by the physiochemical properties
of NFs (Wang et al., 2012). More efforts are required to understand the interplay
between the physiochemical natures of NF scaffolds and the fate of local
osteoblast/osteoclast cells.
Polyvinyl alcohol (PVA) is a biodegradable and biocompatible polymer (Song et al.,
2011a). PVA has good electrospun NF‐forming capability, because of its excellence in
electro‐conductivity (Kim et al., 2008). Kim et al. reported that electrospun PVA/HA
NFs mimic both the architecture (the morphology) and the chemistry (the composition)
of the lowest level of the hierarchical organization of bone (Kim et al., 2008). In our
previous study (Song et al., 2012), we described the physicochemical and biological
properties of electrospun PVA/Col/HA NFs, and found that the inclusion of HA and Col
in the PVA matrix significantly increased the fiber stability and the mechanical strength.
The encapsulated nano‐HA and Col also enhanced the adhesion and proliferation of
osteoblastic MC3T3 cells in vitro. However, these blended PVA/Col/HA NFs cannot be
used as a desired drug release device because of their fast dissolution rate. Thus, to
develop a kind of nanofibers with capability to support sustainable drug release is our
primary goal.
Electrospun NFs can be used as drug release devices by embedding drugs into the
NFs. Biological compounds delivered by NF scaffolds included antibiotics(Feng et al.,
2010), proteins (Sahoo et al., 2010), DNA (Rujitanaroj et al., 2011), and growth factors.
These successes have been achieved either through direct blending of drugs into the
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polymer solution before electrospinning, or via the utilization of coaxial
electrospinning (Gluck et al., 2011). Coaxial electrospinning is a process where a
concentric spinneret can accommodate two different liquids and is regarded as a
significant breakthrough in the field, as shown in Fig.26 (Gluck et al., 2011). During the
coaxial electrospinning a customized spinneret is employed to trap a secondary fluid
layer (containing labile drugs) within the core of the forming NFs (Gluck et al., 2011).
The sheath structure of coaxial NFs acts as a guide and encapsulates the core material.
We utilized biocompatible and biodegradable poly (ε‐caprolactone) (PCL) as sheath
structure of coaxial NFs.

Fig.26 Structure of spinneret for electrospinning coaxial nanofibers

Since we have researched on the monolithic electrospun nanofibers previously
and found its limitations in drug delivery, the objective of this study was to develop a
“bone‐like” implant surface fabricated with coaxial PCLCol/PVAHA core‐sheath NFs used
for controllable sustained release of embedded drugs. The physiochemical and
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biological properties of these NFs were described. The in vitro drug release dynamics
of both Doxy and Dex from these NFs were examined. In addition, the bonding strength
of PCLCol/PVAHA NFs on the titanium rod surface was confirmed.

Materials and Methods

Coaxial electrospinning
10% (w/v) PCL solution was prepared by dissolving 0.5 g of PCL in 5 ml of
dimethylformamide (DMF)/chloroform (1:1, v/v).

PCLcol solution was prepared by

mixing Col (4 mg/ml) with PCL in a ratio of 10:90 (v/v).

The PVAHA solution was

prepared by mixing HA nanorods (Avg. 20‐70 nm) with PVA in a ratio of 10:90 (v/v).
Coaxial electrospinning was performed using a custom made coaxial nozzle consisting
of a hollow stainless steel t‐junction with a fully penetrating 19‐gauge core needle. The
PVAHA solution (for core fiber) and PCLcol solution (for sheath) were uploaded to the
syringes. The syringes were attached to syringe pumps set at a flow rate (Q) of 1 mL/h
for PCLcol and 0.47 mL/h for PVAHA. An 18 kV voltage was applied to the needle from
the power supply. The distance from needle tip to collector was 10 cm. A rotational
speed of 500 rpm was used to evenly deposit the solute on a glass coverslip attached
to the stainless steel hexahedron collector, which was linked to the shaft of a motorized
stirrer. For drug loading purpose, Doxycycline (Doxy), a member of the tetracycline
antibiotics group, and is commonly used to treat a variety of infections, is utilized in
this study. Doxy was firstly dissolved in H2O and then homogenized with PVAHA solution
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or PCLcol solution (350 μg/mL). The mixtures were then electrospun to generate Doxy‐
loaded NFs.
Scanning Electron Microscopy
The coaxial nanofiber scaffold was firstly gold‐coated (Gold Sputter, EFFA Coater,
Redding, CA, USA) and the morphology of the nanofibers was characterized by
Scanning electron microscope (SEM) (JSM‐6510LV‐LGS, MA, USA). Morphologies were
viewed at a 25 kV accelerating voltage.
Transmission Electron Microscope (TEM)
Transmission Electron Microscope (TEM) (JEOL‐2010 FasTEM, USA) was utilized
to characterize the structure of coaxial NFs. NFs were directly depositing onto Cu‐grids
covered with ultrathin carbon layers and observed under an accelerating voltage of
200 kV. Dispersive X‐Ray spectrometry (EDAX) was used to analyze the chemical
composition in area of sample surface of interest. Image J 1.41 software (National
Institutes of Health, Bethesda, MD) was used to determine the average fiber diameter
and pore size by taking measurements from SEM micrographs
Optical Microscope
The core‐sheath structure of nanofibers were also observed under an optical
microscope (HAL 100, Carl Zeiss Microimaging, INC., Thornwood, NY), facilitated with
microscope light source system (X‐cite series 120Q, Lumin Dynamics Group Inc.,
Mississauga, Canada). The fluorescence image of nanofibers embedded with albumin‐
fluorescein isothiocyanate (FITC) was captured also to elucidate the core‐sheath
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structure of NFs.
Contact Angle
The hydrophilicity of coaxial NFs was determined by the contact angle
measurement.

A sessile drop method was applied to measure the contact angle of

nanofibers mesh surface at ambient temperature. The droplets of distilled water were
placed on fibrous surface until equilibrium and contact angles were measured by a
Contact Angle Goniometer (Ramé‐Hart, USA).
Atomic Force Microscopy (AFM)
The surface morphology of nanofibers was characterized by a Multimode IIIa AFM
(Digital Instruments) and a Dimension 3100 AFM (VEECO) as described previously (26).
A Contact Mode was applied to obtain AFM imaging. The integrated optical
microscope was used to position the cantilever on the top of the NFs within
micrometer accuracy. Data were collected by mapping the NFs within a 20×20 μm2
sized grid. The cantilever tip deflection was used as a feedback signal to maintain a
constant force over the scanned area. The nanomechanical properties of the
nanofibers can be studied by AFM force‐versus‐distance curves in Contact Force
Calibration Mode (Blacklock et al., 2010; Mermut et al., 2003). The calculation was
done by analyzing data collected on more than 20 spots using 6 specimens. The force
curves were fitted to the Hertz model and Hooke’s law was used to calculate the
loading force (F) and Young’s modulus. The Young’s modulus (E) for each sample (n=3)
was calculated by finding the slope of the stress (σ) and strain (ε) curve (E=σ/ε). The

74

ultimate strain and stress were determined at the peak load point of the stress‐strain
curve.
Rheological characterization of coaxial NFs
An AR‐G2 rheometer (TA Instruments Inc., New Castle, DL) with an environmental
temperature chamber (ETC) and torsion clamp geometry was used for the rheological
characterization of nanofibers scaffolds. Oscillatory stress sweep and frequency sweep
were firstly employed to determine the linear viscoelastic region (LVR). Then, an
oscillatory temperature ramp was performed to study the thermal behaviors of
nanofibers and determine the heat distortion temperature (HDT). The samples were
scanned in a temperature ramp in oscillatory mode from 40°C to 75°C at a rate of
approximately 2 °C/min with a constant oscillatory stress of 1000 Pa and a constant
frequency of 2π rad/s. Storage modulus (G′), and loss modulus (G′′) were recorded at
an interval of 30 s. The results were shown in supporting information.
Cell culture
Pre‐grown murine MC3T3‐E1 preosteoblast cells (ATCC) were used for the cell
culture. Briefly, coaxial nanofiber scaffolds were placed into petri‐dish. MC3T3 cells
were cultured in α‐MEM (Invitrogen) supplemented with 10% fetal bovine serum
(Invitrogen), 10 mM β‐ glycerophosphate (Sigma), and a 1% (v/v) antibiotic mixture of
penicillin and streptomycin at 37°C in a humidified incubator with 5% CO2. MC3T3‐E1
cells were seeded at a density of 1.0× 104 cells/dish onto placed scaffold surfaces (n=3).
The mitochondrial activity of MC3T3 cells cultured on nanofibers after 8 days was
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determined by MTT assay. Cell viability was also evaluated using the LIVE/DEAD
viability/cytotoxicity staining kit (Invitrogen).
Drug release study
A modified S. aureus growth inhibition assay was used to measure the bactericidal
activity of Doxy eluted from NFs, as we have described previously (24). Briefly, 40 mg
of NFs (encapsulating ~1 mg Doxy) were soaked in 2 ml of Mueller–Hinton broth
inoculated with S. aureus (ATCC#49320, 1 ×102 CFU) and cultured at 37oC. At each time
point, the broth was removed and replaced with the same amount of broth. The
optical density (OD) of collected broth was measured at 625 nm. All the tests were
performed in triplicate and repeated two times. In addition to the bactericidal activity
assay, the release profile of Doxy from NFs has been measured. Briefly, 140 mg of Doxy‐
encapsulated NFs were soaked in 2 mL D‐H2O at 37oC. The Doxy concentration in
supernatant was timely measured via spectrometer at 256 nm. Similarly, 140 mg of
Dex‐encapsulated‐NFs were soaked in 2 mL D‐H2O and the release profile of Dex was
also plotted.
Bonding strength of implant
To determine whether the NF coating remained intact during implantation, we
developed an ex vivo porcine bone implantation model. Since the bone mineral
density of porcine proximal tibia (1.42 g/cm2) is closer in value to young human
proximal tibia (1.30 g/cm2) (Nagarkatti et al., 2001), we selected porcine proximal
tibia bone for Ti rod implantation. We purchased fresh‐frozen porcine knee specimens
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from a local slaughterhouse and stored them at ‐20oC. The specimens were thawed
overnight and all soft tissues were removed before testing. A flat dissected bony
surface was obtained after removing all superficial articular tissues. The tibial bone
holes (diameter = 2.54 mm; depth = 15 mm) were made. We deposited electrospun
PCLcol/PVAHA NFs directly on the surface of Ti rods (diameter = 2.5 mm, length = 60 mm)
covering the entire surface of the Ti rod stem. The thickness of the NFs coating is ~
50μm. We slowly inserted NFs coated Ti rods into the bony holes using an Instron
model 8841 Universal Materials Test Machine at the speed of 10 mm/min. The porcine
bones with Ti rod implantation were then soaked in sterilized PBS at 37oC for 2 or 7
days. At each time point, the Ti rods were pulled out from the bone holes (n=3).

Results and Discussion
PCLcol/PVAHA core‐sheath NF scaffolds for controlled drug release:
We developed a novel core‐sheath NF composed of PCL and PVA through coaxial
electrospinning. Since PCL lacks biological recognition sites, we incorporated Col into
the PCL sheath (PCLcol) to increase its cytocompatibility. The exposure of the internal
amino acid sequence (Arginine‐Glycine‐Aspartic acid, RGD), due to the partial
denaturing of Col in the organic solvent of PCL solution, provided numerous binding
sites for the enhancement of cell adhesion and proliferation (Ekaputra et al., 2009;
Taubenberger et al., 2010). The slow‐degrading PCLCol sheath provided a physical
barrier for the slow drug release (Natu et al., 2011). We incorporated HA into the PVA
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core (PVAHA) to increase the surface roughness and mechanical strength of NFs. The
exposure of some HA nanorods outside of the NF surface provide numerous functional
anchoring sites for cell adhesion and proliferation. The PVAHA core was used to mimic
the bone structure and used as a reservoir for drug loading.

Fig. 27 Morphology of core‐sheath NFs consisting of PCLCol sheath and PVAHA core. (a,
c) Electrospun NF mesh on coverslips (original magnification, 100x and 400x,
respectively).The red arrow indicates the embedded HA nanorods in the core fiber
(c); (b) A representative fluorescence/visible image of core‐sheath structure of NFs
(Albumin‐FITC encapsulated in the PVAHA core as indicators, original magnification,
400x). The black arrow indicates a distinguishable core‐sheath NF structure. The
white arrow shows a distribution of albumin‐FITC in both the core and sheath site in
some segments, suggesting a diffusion of albumin from core to the sheath during
electrospinning. The incorporation of both Col and HA nanorods formed a rough
surface and numerous micro‐projections, which are expected to increase the surface
area of NFs and provide a favorable condition for cell growth; and (d) Representative
image of PCLCol / PVAHA NFs 24 h after being soaked in water (original magnification,
100x). The integrity of the NF structure was still intact. The insert shows the contact
angles on the surface of NFs with and without incorporation of Col and HA. A slight
increase of the contact angle was observed by incorporation of Col and HA (yellow
arrow).
Characterization of PCLcol/PVAHA core‐sheath NFs:
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As shown in Fig.27, a distinguishable core‐sheath structure of NFs was identified.
Some of NFs showed a co‐continuous (multi core‐sheath) structure instead of a typical
core‐sheath structure. The finding of a distribution of albumin‐FITC in both the core
and sheath site in some segments of NFs suggested a diffusion of albumin from core
to the sheath during electrospinning (Fig.27, b). The embedding of Col and HA formed
a rough surface and numerous micro‐projections, which are expected to increase the
surface area of NFs and provide a favorable condition for cell growth. Surface
wettability of NFs is critical for cell adhesion, proliferation, and migration (Kim et al.,
2006a). Using a Contact Angle Goniometer, we found that the incorporation of Col in
PCL and HA in PVA increased the contact angles of NFs (Fig. 27d, insert). SEM analysis
(Fig.28) demonstrated that the mean average fiber diameter was 948 ± 179 nm. The
average pore size was 96 ± 30 μm. The dimension of fibers is capable to encapsulate
nano‐HA rods in average size of 20‐70 nm. The elemental composition analysis of NFs
by EDAX showed the presence of Ca (from HA), C and O (from PVA, PCL), and N (from
albumin and Col). A sharp boundary between the sheath and core fibers was observed
by TEM (Fig.29). The formation of distinguishable core‐sheath NF structures results
from the immiscibility of the two polymer solutions during electrospinning. We
noticed that HA nanorods were properly embedded in the PVA core and some HA
nanorods protruded through the PCL sheath layer. The core‐sheath fiber ratio is ~1:5.
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Fig. 28 SEM micrograph of PCLCol/PVAHA coaxial NFs (upper panel) and elemental
composition of NFs by EDAX analysis on single NF (bottom panel).
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Fig. 29 Representative TEM images of PCLCol/PVAHA coaxial NFs (a) Overlapping NFs
showing distinguishable core‐sheath structure, and (b) The ratio of sheath/core fiber
diameter is approximately 4:1.
Atomic force microscopy (AFM) of PCLCol/PVAHA NFs:
We investigated the morphology and mechanical property of both blended PVA
NFs and The surface roughness of NFs was measured from the height images on the
encapsulated HA nanorods (Fig. 30, A) in PCLCol/PVAHA NFs. In agreement with AFM
images the Young’s modulus (E) of PCLCol/PVAHA NFs (3.12 MPa) was significantly higher
than that of the pure PVA NFs (0.83 MPa, p< 0.05) (Fig. 30, C). Our data indicate that
the stiffness of PCLCol/PVAHA NFs is higher than blended PVA NFs. The potential impacts
of NFs stiffness on cell behaviors will be carefully investigated.
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Fig. 30 3D AFM contact mode height images of (A) PCLCol / PVAHA coaxial NFs and (B)
PVA NFs on Ti disc. (C) The mean Young’s modulus (E) of single NF (n=6).
*p < 0.05
Sustained release of Doxycycline (Doxy) and dexamethasone (Dex) loaded in
PCL/PVA NFs:
The release of Doxy and Dex from both blended and coaxial core‐sheath NFs was
studied and the results are shown in Fig.31. NFs (blended or core‐sheath) with Doxy
loading were prepared. As shown in Fig.31 (B), blended PVADoxy NFs showed a burst
release of Doxy within 10 h, and the release was complete within 48 h. When the PCL
sheath was added to create the coaxial PCL/PVADoxy NFs, an extended Doxy release for
over 700 h was observed, due to the protection of the slow‐degrading PCL sheath.
When Doxy was also loaded in the PCL sheath fibers (PCLDoxy/PVA), both the burst
release and the extended bacterial growth inhibition were increased when compared
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to PCL/ PVADoxy NFs, as shown in Fig.31 (A). This might be due to the early erosion of
the PCL sheath fiber. With the loading of Doxy in PCL sheath fibers bacterial growth
inhibition is increased at first stage, as compared to PCL/PVADoxy NFs. Taken together,
Doxy embedded in NFs during coaxial electrospinning is stable and its bactericidal
activity is effective in a long term. We found that the blended PCL NFs (no Doxy loading)
showed a gradual increase of bacterial growth inhibition, which might be due to the
potential effects of PCL degradation products on S. aureus growth. Beyond 152 h
(phase II), all PCL‐containing NFs (with or without Doxy loading) showed a similar
extent of bacterial growth inhibition, indicating complete Doxy release after 152 h. In
conclusion, coaxial PCL/PVA core‐sheath NF scaffolds represent a better device for a
sustained and sufficient (> minimal inhibitory concentration) antibiotic release for at
least 152 h. The Dex release profile is similar to the release of Doxy (Fig. 31). NFs
weighing about 40 mg (encapsulating ~ 0.1 mg Dex) were soaked in 20 ml of sterilized
distilled water in glass vials and incubated at 37oC. At each time point, 1 ml of the
supernatant was removed from the vial, and replaced by an equal volume of fresh
water. The concentrations of Dex (at OD of 242 nm) in the supernatant were then
determined using a UV–vis spectrophotometer. Similar to Doxy, blended PVADex NFs
showed a burst release within 10 h, and Dex was completely released within 48 h.
Coaxial PCL/PVADex NFs significantly extended Dex release for over 150 h. A slight
increase of Dex burst release was found when Dex was added in PCL sheath
(PCLDex/PVADex).
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Numerous studies have dealt with applying coaxial electrospinning for
encapsulation of drugs in either the core or sheath or both (Huang et al., 2006). The
sheath structure represents a physical barrier to reduce the initial burst release and
protects the drugs in the core fiber. Drug release from NFs mainly relies on diffusion
(Szentivanyi et al., 2011). The concentration gradient inside the core polymer matrix is
the driving force for diffusion. In diffusion across a barrier (sheath), the driving
concentration gradient is between the reservoir (core) and the release environment,
which are separated by a barrier (sheath). In such a core‐sheath system, a drug release
rate is affected by both the concentration gradient and the degradation rate of the
barrier. Therefore, control of the drug release rate can be achieved by preparation of
various formulations and thicknesses of slow/fast‐degradation sheath fibers and/or
modification of physiochemical properties of NFs. We propose that the release of Doxy
seems to be via diffusion and an erosion‐coupled mechanism. The initial Doxy release,
mainly due to the diffusion and surface erosion of the PCL sheath, provides an instant
protection against bacterial adhesion and growth. Subsequently with the slow‐
degradation and hydrolysis of the PCL sheath, a controllable and sustained Doxy
release is expected through a diffusion of Doxy from the core fiber crossing a degrading
PCL sheath barrier, until the release is completed. In conclusion, coaxial core‐sheath
NF scaffolds are capable of providing controllable and sustained drug release, which is
crucial for the implant osseointegration, because BMSCs require sufficient and
sustained osteogenic signals for their differentiation and maturation, leading to new
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bone formation.

Fig.31 Drug release profiles. (A) A semi‐quantitative S. aureus growth inhibition for
release solution from NFs (blended or coaxial core‐sheath) with/without Doxy
incorporation at predetermined time points; (B) The cumulative concentration of
Doxy released from NFs soaking in distilled water up to 700 h. (C) The cumulative
concentration of Dex released from NFs soaking in distilled water up to 218 h. n=3.
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Viability and proliferation of MC3T3 cells grown on PCLCol/PVAHA NFs:
Live–dead cell staining was utilized to determine the cellular response to
PCLCol/PVAHA NFs by simultaneous monitoring of viable and dead cells after culturing
for 3 days. No difference for red‐stained dead cells was found between cells cultured
on coverslips with (Fig. 32B) and without (Fig. 32C) PCLCol/PVAHA NFs. Results of the
MTT assay showed that MC3T3 cells cultured on PCLCol/PVAHA NFs had a higher
proliferation rate than that of cells cultured on coverslips. However, there is no
statistical significance (p>0.05). It is well recognized that the cell behavior is largely
influenced by the physiochemical properties of NFs. We found that the embedding of
HA nanorods in electrospun PVA NFs significantly increased the surface roughness and
mechanical strength of NFs, leading to the enhancement of cell adhesion, proliferation
and differentiation. It is likely that a wide variability in NF diameters or the presence
of a certain amount of large spaces might lead to the inferior cell adhesion and/or
proliferation, because of the reduction of surface area. The cell adhesion and growth
on the NF scaffolds can be enhanced by the embedded biological compounds, such as
HA and Doxy. The loosely interlaced fibrous structures provide minimal obstruction
and matched mechanical properties for cell migration. The living cells entering into the
NF matrix by amoeboid movement migrate through the pores by pushing the
surrounding fibers aside, because nanoscale NFs offer little resistance to the cell
movement.
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Fig.32 Viability and proliferation of MC3T3 cells grown on coverslips with and
without coating of PCLCol/PVAHA NF scaffolds. (a) MTT activity assay for proliferation
of MC3T3 cells for 8 days (Control: glass coverslips without NFs); (b, c) The live
(green)‐dead (red) staining (original magnification, 200×) of MC3T3 cells cultured on
coverslips with (b) and without (c) coating of PCLCol/PVAHA NF scaffolds for 3 days.
n=3
Characterization of bonding strength of PCLCol/PVAHA NFs to the titanium implant:
To determine whether the NF coating remained intact during implantation, we
developed an ex vivo porcine bone implantation model. The maximum shear force
required for insertion of NFs coated Ti rod was 20 N (shear stress = 0.17 MPa). The
porcine bones with Ti rod implantation were then soaked in sterilized PBS at 37oC for
2 or 7 days. At each time point, the Ti rods were pulled out from the bone holes. The
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force required to pull out the Ti rods from bone holes at 2 days was 10 N (shear stress
= 0.085 MPa). We found that NFs coating remained intact on the surface of Ti rods
after pullout. No disruption or delamination could be observed in the distal part of Ti
rods (inside of bone), as compared to the proximal part of Ti rods (outside of bone).
Our data showed that the bonding strength of NFs to the smooth surface of the Ti rods
was higher than 0.17 MPa of shear stress.

Fig.33 A flow chart of the Ti rod implantation and pullout procedure in a porcine
bone implantation model. Holes were drilled in the dissected surface of porcine
proximal tibia (diameter= 2.54 mm, depth= 15 mm). Ti rods (diameter = 2.5 mm,
length= 60 mm) deposited with PCLCol/ PVAHA coaxial NFs (thickness= 50 μm) were
slowly inserted into the drilled holes (rate= 10 mm/min) and the shear force was
recorded. Ti rods inserted into tibia bone were soaked in sterilized PBS at 37°C for 2
or 7 days. Rods were subjected to a pullout test with the same rate and the shear
force was recorded (n=3). Pulled out Ti rods were analyzed by SEM. The line drawn
across the rod shows the border of Ti rod after pullout (in/out bone tissue).
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Fig.34 SEM micrograph of PCLcol/PVAHA core‐sheath NFs deposited on the surface of
Ti rods by coaxial electrospinning. The Ti rods were pulled out from bone holes
after incubation in sterilized PBS at 37oC for 2 and 7 days, respectively (10000 X).
Dark line in the picture showing the interface of inside/outside of bone holes .
In separate experiments, SEM was used to measure the microstructure changes
at the NFs/Ti interface of Ti rods pullout. As shown in Fig. 34, SEM images showed that
the NFs network matrix remained intact and distributed evenly on the Ti rod surface.
Partial degradation of NFs (both in and out of bone holes) could be found, especially
after 7 days of incubation in PBS at 37oC. The partial degradation of NFs did not induce
a significant change of NF diameters. Shear force applied (during insert and pullout)
did not cause any visible disruption, delamination or folding of the NFs on the Ti rod
surface. As compared to the NFs on the proximal part of Ti rods (outside of bone),
the NFs matrix on the distal part of Ti rods (inside of bone) was less swollen, probably
due to the defined space within the bone holes during soaking period. The NFs in the
bone holes showed a much rougher surface than the NFs outside of bone. It might be
due to the precipitation of biological apatite nanocrystals released from surrounding
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bone onto the NF surface. In vivo, NFs with biological apatite layer incorporates
proteins and promotes the adhesion of osteoprogenitor cells that would produce the
extracellular matrix of bone tissue. Taken together, our data ensured that the NFs
coating remains intact during implantation. This is important for the proposed study,
because the drug loaded on the NFs coating layer will not be disrupted and the desired
drug release dynamics can be expected.
The goal of this study is to demonstrate whether coaxial PCL/PVA NFs represent
dual functional devices in enhancing implant osseointegration and eliminating bone
infection. We have demonstrated NFs coating was capable to support local drug
delivery in a sustained manner and effectively inhibit MRSA infection in vitro. In future
study, a rat implantation model with MRSA infection will be utilized to further elucidate
the impact of incorporation of antibiotics in the coaxial NFs on bactericidal activity and
cellular responses (adhesion, growth and differentiation) in vivo. Additionally, a rat
tibia implantation model is planned to be utilized for NFs coated Ti rod. The
osseointegrationon NFs coatings would be characterized via a sodium fluoride (F18‐
NAF) PET imaging technology to identify the new bone formation. Histology imaging
would also be applied to support the evidence of osseointegration.

Conclusion
In this study, we developed PCLCol/PVAHA coaxial electrospun NFs with defined
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physiochemical and biological properties in order to enhance implant osseointegration.
We demonstrated that the coaxial NFs encapsulated Doxy were able to Inhibit MRSA
colonization and subsequent infection via controlled release of Doxy. The viability of
loaded drug in PVA core phase was greatly improved by the barrier protection of PCL
sheath structure. PCLCol/PVAHA coaxial NFs showed good biocompatibility and
osteoconductivity. Taken together, PCLCol/PVAHA coaxial NFs could be applied as
promising nanofabricated coatings with drug biomolecules/drugs loading capacity to
promote earlier and sufficient implant osseointegration and prevent implant infections.
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CHAPTER 6 IMPLANT SURFACE FABRICATION WITH COAXIAL NANOFIBER COATING
TO ENHANCE EARLY IMPLANT OSSEOINTEGRATION IN A RAT MODEL
Introduction

Our previous study has demonstrated coaxial electrospun PCL/PVA nanofibers
have excellent potential to be applied as implant surface modification materials. The
purpose of this study was to evaluate its ability of inducing osseointegration and
bacteria inhibition in vivo.
Many implant surface fabrication techniques have been developed with the aim
of improving osseointegration (Anselme et al., 2010). However, current clinical studies
found no significant improvement in clinical outcomes in patients (Steens et al., 2010).
The weakness in adhesion, brittleness and burst drug release largely limits the current
coating technology for further application, as addressed in previous chapters. Our
previous study (Ren et al., 2010) showed that around 75% of the total amount of
erythromycin loaded onto a titanium rod with HA coating was released within 24 h.
Current studies demonstrated that the nanoscale topography of the implant surface is
critical for earlier osseointegration (Gittens et al., 2011) and sustained drug release (Su
et al., 2012b).
We have demonstrated that electrospinning was one of the promising
technologies to fabricate nanofibers that can mimic bone nanoscale extracellular
matrix (ECM) structure, as shown in previous studies. The potential application of
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electrospun NFs for the enhancement of osseointegration is promising but obviously
overlooked. We found three papers(Wang et al., 2011; Kohgo et al., 2011; Huang et al.,
2008) demonstrating that the NF structural cues alone can be used to create an
osteogenic environment without the use of exogenous factors(Wang et al., 2011). The
cell attachment, proliferation, and differentiation of osteoblastic cells in vitro are
significantly influenced by the physiochemical properties of NFs (Wang et al., 2011;
Huang et al., 2008). More efforts are required to understand the interplay between
the physiochemical natures of NF scaffolds and the fate of local osteoblast/osteoclast
cells.
Animal models for studies of implant osseointegration typically involve the use of
large animals such as dogs, sheep and rabbits. Although these models have the
advantages of large bone/joint size and the ability to use a realistic prosthetic implant,
the cost and ethical issues prevent broad employment of large animals. In this study,
we used a rat tibia implantation model (Ren et al., 2012). Titanium (Ti) pins were
inserted into the proximal tibia. This model is simple and highly reproducible. This
model has been widely used for the evaluation of implant osseointegration by local
drug delivery and implant surface modification (Li and Nilsson, 2001; Xu et al., 2011;
Mekraldi et al., 2003).
Positron Emission Tomography (PET) provides information on distribution and
kinetics of injected radiotracers in vivo.

18

F‐Fluoride (18F‐NaF) was used as a bone

imaging agent nearly 40 years ago. After diffusion through bone capillaries into bone
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extracellular fluid, F‐ ion exchanges with hydroxyl groups in the hydroxyapatite crystal
to form fluoroapatite. F‐ is preferentially deposited at the bone surface where turnover
is greatest.

18

F‐NaF has been used as a clinical routine to detect cancer metastatic

lesions to the bone that is important for diagnosis and staging. Whereas the clinical
value of 18F‐NaF in detecting metastatic bone disease is validated, its clinical value to
assess implant osseointegration has not been firmly established.
The objective of this study was to determine the therapeutic efficacy of these NF
scaffolds in vivo for the implant osseointegration using a rat model. We propose that
Ti with NF coating significantly enhanced implant osseointegration and PET 18F‐NaF
can be used to quantitatively and noninvasively evaluate the implant osseointegration
in vivo.

Materials and Methods

Study design
To determine whether Ti with nanofiber coating increased implant
osseointegration in vivo, total six rats were included in this study. Rats were divided
into two groups:

Ti pin with (n=3) and without (n=3) nanofiber coating.

Rats were

PET scanned at 2, 4 and 8 weeks after Ti pin rat tibia implantation.
Preparation of coaxial nanofibers and Titanium coating
10% (w/v) PCL solution was prepared by dissolving 0.5 g of PCL in 5 ml of
dimethylformamide (DMF)/chloroform (1:1,v/v).

The 10% PVA solution was
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prepared by dissolving PVA in distilled water. Coaxial electrospinning was performed
using a custom made coaxial nozzle consisting of a hollow stainless steel t‐junction
with a fully penetrating 19‐gauge core needle. The PVA solution (for core fiber) and
PCL solution (for sheath) were uploaded to the syringes. The syringes were attached
to syringe pumps set at a flow rate (Q) of 0.5 ml/h. An 18 kV voltage was applied to
the needle from the power supply. The distance from needle tip to collector was 10
cm. A rotational speed of 500 rpm was used to evenly deposit the formed nanofiber
on the Ti pin attached to the stainless steel hexahedron collector, which was linked to
the shaft of a motorized stirrer. For this in vivo study, we deposited electrospun
PCL/PVA NFs directly on the surface of Ti pin (diameter = 1 mm, length = 10 mm)
covering the entire surface of the Ti pin stem. The thickness of the NFs coating is ~ 50
μm, measured by a micrometer and SEM. Ti pins with NFs coating were sterilized by
UV light overnight right before implantation. We found that UV irradiation is a very
effective sterilization method and has least effects on the morphology and structural
properties of NF structures.
Rat tibia implantation model
All research protocols of animal use were approved by the Institutional Animal
Care and Use Committee of Providence Hospital and Wayne State University. Sprague
Dawley (SD) rats (female, body weight of 200g‐300g) were anesthetized by intra‐
peritoneal injection of ketamine (75 mg/kg) and xylazine (8 mg/kg). The right hind limb
area was shaved and sterilized with 70% alcohol. The center of tibial plateau was
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reamed to form a circular indent of 1.5 mm diameter and 0.5 mm depth. The proximal
5 mm of the tibial intramedullary canal was reamed with a 0.8 mm dental drill through
the center of the plateau. A titanium (Ti) pin (diameter 1 mm, length: 10 mm, Stryker
Orthopaedics, NJ) with/without nanofiber coating was implanted into the proximal
tibia to form part of a knee joint, as shown in Fig.39. The wound was cleaned and
rinsed with sterilized saline containing Penicillin G (500 unit/ml) and Streptomycin (500
µg/ml) before being closed by suture in layers.
Histomorphometry
We followed the methods, as described by Dr. Jiang (Jiang et al., 1997; Jiang et al.,
2003). During the distal tibia bone segments (including part of the Ti pin) were fixed
and dehydrated in graded ethanol (70‐99%) and defatted in acetone. Specimens were
then placed in 99% propanol before being embedded in cold poly(methylmethacrylate)
(PMMA) without decalcification. Perpendicular to the tibia shaft, each specimen was
sectioned in 100‐μm thick slices using a rotary diamond saw. The sections were ground
to a thickness of ~ 30 μm by Leica SP2600 (Germany), and then stained with 1%
toluidine blue. Bone‐to‐implant contact (BC) was calculated as the linear percentage
of the interface with direct bone‐to‐implant contact to total interface of the implant in
the cancellous bone. Bone area ratio (BA) was measured as the area percentage of
bone tissue to the whole area, which will be defined as a ring extending 200 μm from
the implant surface.
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μPET scanning protocol.
Imaging was performed using the μPET R4 tomography (Concorde Microsystems,
Knoxville, TN). Rats were anesthetized with a mixture of ketamine (100 mg/kg) and
Xylazine (7 mg/kg) using a nose cone and positioned in spread supine position on the
μPET bed. In order to achieve reproducible positioning of the rat in the μPET and μCT
scanner gantry, we used an in‐house developed whole body holder. The holder consists
of a short plate on which the animal's body rests and is secured with multiple Velcro
straps as well as with head positioning screws. Attached to the holder are three fixed
plastic receptacles of 5mm diameter in which porous beads can be inserted. These
beads are visible in both the μPET (radioactivity) as well as in the μCT (plastic) images
and were used for co‐registration of the two imaging modalities. Initially, a 17 min
transmission scan was acquired to correct for attenuation of 511 keV photons.
Following the transmission scan, the rats were injected with the tracer

18

F‐NaF (10

MBq) and a 60 min list mode scan was acquired. A subset of mice will be kept overnight
and the 18F‐NaF scan was repeated, following injection of unlabeled tetracycline (10
μg/ml) in order to determine the amount 18F‐NaF displacement with cold TC. The list
mode data were recombined into a frame sequence (6 x 10s, 4 x 30s, 2 x 120s 3 x 300s,
4 x 600s) and all images were subsequently reconstructed using measured attenuation,
scatter correction, and the OSEM2D iterative algorithm, yielding images with an
isotropic resolution of about 2mm FWHM. At the conclusion of the 18F‐NaF scan the
animals were sacrificed, and knee joint tissues (implanted and un‐implanted controls)
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were collected for histological and SEM analysis.
μPET data analysis
A calibration factor was routinely established in our micro‐PET facility, which is
subsequently used to convert counts/pixel/min to units of μCi/cc for the PET tracers.
All images were processed using the AMIDE data analysis software. Initially, regions of
interest (ROIs) were defined bilaterally at the location of the tibia joint in μCT images
and copied to the co‐registered PET images. In addition, a small ROI was defined at the
location of the left ventricle (LV) in early PET image frames (showing the bolus activity)
in order to obtain the arterial input function. Subsequently, time‐activity curves were
obtained and used to estimate kinetic parameters using a two‐tissue (parameters K1,
k2, k3) kinetic model. This model has been shown to accurately characterize 18F‐NaF
tracer uptake. A semi‐quantitative analysis of tracer uptake was performed using the
standard uptake value (SUV), which is defined as the tracer concentration in tissue
(μCi/cc) normalized to the injected activity (μCi) per weight (g). Tracer concentration
was obtained by averaging 10‐30 minutes of the dynamic acquisition.
SEM methodology
The harvested Ti pin sample from rat tibia was firstly fixed in 4%
paraformaldehyde for 30 min. Then samples were orderly dehydrated in 50%, 60%,
70%, 80%, 90%, 100% ethanol for 10 min, respectively. Before SEM observation,
samples were gold‐coated (Gold Sputter, EFFA Coater, Redding, CA, USA) and the
morphology of Ti pin surface was characterized by Scanning electron microscope (SEM)

98

(JSM‐6510LV‐LGS, MA, USA). Morphologies were viewed at a 25 kV accelerating
voltage.
Push‐in test
The proximal parts (with Ti pin) of tibia samples used for push‐in testing. Soft
tissue around the tibia was removed to expose the surface of the implanted Ti pin head
and proximal tibia. The dorsi side of the tibia sample was then fixed into a self‐
manufactured aluminum fixture with a central cylindrical hole, as shown in Fig.36 (c).
The inserted tibia was stabilized by facilitated screws from four directions.
Approximate alignment was achieved by positioning the tibia parallel to push‐in probe
with the loading axis of the Instron model 8841 Universal Materials Test Machine.
Proper specimen alignment was obtained by adjusting the two rotational axes of the
fixture while using continuous fluoroscopy to confirm perpendicularity of the pins with
respect to the fixture base. Once the fixture is attached to the load cell, the fixture
aligned along the x‐axis and y‐axis cross slides to obtain alignment between the
extraction pin and the implants. Under position control, the Instron 8841 actuator
pushed the Ti pins into the bone marrow at a rate of 1 mm/minute. Actuator position
and load recorded by a PC using software. The Ultimate Shear Strength (the peak push‐
in force) and energy for complete pin push in (integration of push‐in force and
displacement) was used to reflect the osseointegration of interface.
Statistical Analysis
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Initially, regions of interest (ROIs) were defined bilaterally at the location of the
knee joint in microCT images and copied to the co‐registered PET images.
Subsequently, the BP and SUV values were derived from the operated (R) and non‐
operated (L) knee joint and used to calculate the asymmetry index (AI) defined as

yielding for the two groups the AI(BP) and AI(SUV). A comparison of these two
AIs within each group was conducted using the Wilcoxon sign rank test for non‐
parametric data, whereas comparison between the two groups was made using the
Mann‐Whitney U test. A p value of less than 0.05 was considered to be a significant
difference. All data was analyzed using the SPSS software package (version 7.5;
Chicago, IL).

Results
SEM analysis
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Fig. 35 SEM micrograph of NF‐coated Ti‐pin implanted in rat tibia and the
surface elemental analysis by EDAX. Red arrows: cells; Yellow arrows: nanofibers.
As shown in Fig. 35, the surface morphology of NF‐coated Ti pin harvested from
Rat tibia after 2 and 4 weeks of implantation was obtained from SEM micrograph. In
comparison with Ti pin without NF coating at 2 week time point, NF‐coated Ti pin has
rough surface created by NFs. The nanostructure of NF can still be observed (yellow
arrow) and the NF coating remained firmly attached to the Ti pin surface after 2 weeks
of implantation. This result indicated the delamination of NF coating contacted with
surrounding bone tissue was not occurred during implantation. At 4 week time point,
bone cells attached to NF matrix can be clearly viewed, and the cell showed a well
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spread and proliferative morphology, which indicated bone cells started migration and
proliferation on NF coated‐Ti pin surface within 2‐4 weeks. Ti pin without NF coating
showed no attached cells, which indicated its bio‐inert property. EDAX elemental
analysis on area of interest with large amount of cells was performed. The spectrum
showed high amount of N that does not come from either Ti pin or NF coating. The
only possible source of N is from extracellular matrix. This result confirmed the bone
cells laid down high content of extracellular matrix (possibly collagen) within 4 weeks,
which is crucial for initiation of bone remodeling. The implanted NF‐coated Ti pin
showed magnificent biocompatibility and osteoconductivity, which presents
improvement for enhancing Ti‐based implant osseointegration.
Mechanical testing

Static friction force (N)

20

Push‐in test

15
10
5
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No NF

NF
(a)
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Fig 36(a) a pilot study of Rat tibia implanted Ti‐pin push‐in test. Rat tibias were
harvested after implantation for 8 weeks. n= 5. (b) representative force vs
displacement curve for push‐in test. The static friction force was determined as
Push‐in force.
Fig.36 shows that the present study gives push‐in forces that are within the range
reported by previous studies (Yang et al., 2007). For Ti pin inserted into rat tibia, the
presently measured range of composite bone push‐in loads 5‐20 N. When push in load
was vertically applied to Ti‐pin in y direction, friction force was generated from
interface between NF coating and surrounding bone tissue. Ideally, the static friction
force was constantly increased until the maximum static friction force was reached. In
general, this progress takes about 0.1 mm of displacement to achieve due to the plastic
behavior of polymer based NF matrix and then the Ti pin will start to move. A constant
dynamic friction force will be recorded. The maximum friction force was determined
to be the push in force to reflect the bonding force between NF coating and
surrounding bone tissue. After 8 weeks of implantation, bonding strength of Ti‐bone
was detected in a range of 10 N (control), which indicated the osseointegration was
occurred. The push in force of NF groups is a little higher than Non‐NF group though
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not significantly, which indicates the NF coating provides some positive effect on
bonding strength between bone and implant. We hypothesize that longer duration of
implantation might show larger difference between NF groups and Non‐NF groups.
PET data analysis

(a)

(b)
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(c)

(d)

(e)

Fig. 37 F18‐fluoride PET images of a rat with non‐NF‐Ti pin (a) and NF‐Ti pin (b).
Uptake of tracer shows significant asymmetry between the operated (left, arrow
indicated) and control (right) tibia. A standard uptake value (SUV) from (c) non‐NF Ti
pin implantation side (left) and control (right); (d) NF Ti pin implantation side (left)
and control (right); (e) comparison of non‐NF Ti pin implantation and NF Ti pin
implantation.
Representative PET images are shown in Fig. 37. As shown in Fig. 37, for both non‐
NF‐Ti pin (a) and NF‐Ti pin group, the operated (left) tibia SUV values were obviously
higher than control (right) group. It also can be observed that the gap of non‐NF‐Ti pin
tibia to control is much smaller than NF‐Ti pin tibia to control. Accordingly in
comparison, SUV of NF‐Ti pin group was also higher than non‐NF‐Ti pin group values.
It confirmed that Ti‐pin implantation enhance the new bone formation. Moreover, NF
coated Ti pin further improved the osseointegration to Ti‐pin surface.

105

Hard tissue sectioning
Bone

Ti

Fig. 38 Histological images of the bone/Ti pin interface 8 weeks after
implantation (a, Uncoated; b, coated; H&E stain, original magnification ×100);
and results of the BC (c) in histomorphometry. Data are expressed as mean
±SD, n =3 per group. *p< 0.05.
As shown in Fig.38, image analysis of tissue sections stained with hematoxylin and
eosin showed that new bone formation around implant were characterized by
increased (H&E +, red) osteoblast proliferation. It was observed that NF coated Ti pin
significantly increased osteoblasts proliferation and activity as compared with
uncoated Ti pin. Quantitative image analysis, as shown in Fig.38 (c), revealed that NF
coatings significantly induced osteogenesis (P < 0.05).

A
B

C

Fig.39 μCT: (A) Ti pin implantation at implant/bone interface; (B)
cross‐section and (C) reconstructed longitudinal section.
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Discussion

In previous study, we found that the PCL/PVA NFs are biocompatible and enhance
the adhesion and proliferation of murine osteoblastic cells. The release of Doxy from
coaxial PCL/PVA NFs showed more controlled release compared with the blended NFs.
Using an ex vivo porcine bone implantation model we found that the PCL/PVA NFs
bind firmly on the Ti pin surface and the NFs coating remained intact on the surface of
Ti pin after push‐in. We propose that PCL/PVA NFs encapsulating drugs have great
potential in enhancing implant osseointegration in vivo. In this continuing study, we
used a rat tibia implantation model (Ren et al., 2010) to determine the effects of Ti pin
with PCL/PVA NF coating on the implant osseointegration in vivo. Pins were inserted
into the proximal tibia. This model is simple and highly reproducible. This model has
been widely used for the evaluation of implant osseointegration by local drug
delivery(Back et al., 2012) and implant surface modification(Cheng et al., 2012).

The

tibia implantation model is designed so that cyclical loading is transmitted to the bone‐
implant interface to mimic post‐operative mechanical environment. Our data
demonstrated that Ti pin with nanofiber coating increased implant osseointegration
as compared to that of uncoated Ti pins up to 8 weeks.
To date, reliable visualization of the intensity and distribution of new bone
adjacent to an implant soon after surgery is still lacking. There is clearly a need to
establish noninvasive, accurate and specific diagnostic tools for the monitoring the
status of implant osseointegration. This is of particular importance, as the prognosis
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and treatment plan is completely different for those with dysfunctional implant
osseointegration. PET imaging has been established as a major research tool in many
areas of life science, clinically relevant applications of molecular imaging in the
orthopedic field have been limited (Su et al., 2012a).

18

F‐fluoride (18F‐NaF) is a

nonspecific bone tracer that has been used for skeletal imaging since the late 1960's.
Diffusion through capillaries into bone extracellular fluid leads to a slow exchange of
fluoride ions with hydroxyapatite crystals forming fluoroapatite. Due to the fact that
remodeling and bone turnover is greatest at the surface, it is mainly stored there
(Gluck et al., 2011). Moreover, the “first‐pass” extraction of

18

F‐NaF from blood

through the capillary membrane into the bone is almost 100%. The use of 18F‐NaF in
the evaluation of implant osseointegration has been so far limited(Su et al., 2012a; Kim
et al., 2008; Ren et al., 2010). Uilmark et al. (Back et al., 2012) used 18F‐NaF PET to
monitor new bone formation in periacetabular bone adjacent to the implant in 16
bilateral THA patients 1 week, 4 months and 12 months after surgery and concluded
that

18

F‐NaF PET is a valuable tool to analyze bone formation and secondary

stabilization of acetabular cups. In another study (Cheng et al., 2012), these same
investigators found

18

F‐NaF PET imaging to be a useful method for evaluating the

healing of morselized bone allograft, impacted in large osteolytic acetabular defects at
revision arthroplasty. Nevertheless, the number of publications describing the use of
18

F‐NaF PET imaging for orthopeadic application is rather modest. In this study, we

found that 18F‐NaF PET imaging is helpful to semi‐quantitatively evaluate the status of
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implant osseointegration. There is a general correlation between 18F‐NaF tracer uptake
and histomorphometric parameters and SEM description.
Consistent with the PET imaging findings, the SEM analysis demonstrated the
evidence of implant osseointegration at both 2 and 4 weeks after implantation.

In

addition, histology data showed that there was an improvement of implant
ossoeintegration in the Ti pins with nanofiber coating, as compared to that of Ti pin
without NF coating 8 weeks after implantation.
One of the limitations in this study is that the sample size is small and was
conducted as a proof‐of‐concept experiment. Though we demonstrated a higher
implant osseointegration in the rats with coated Ti pins at any given time points as
compared to that of uncoated Ti pins, no significant difference could be established,
thus follow‐up studies with larger sample size are warranted.
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CHAPTER 7 IMPLANT SURFACE WITH DOXYCYCLINE‐DOPED NANOFIBER COATING
TO TREAT IMPLANT INFECTION IN RAT MODEL

Introduction
The purpose of this investigation is to determine whether NFs doped with certain
amounts of Doxycycline (Doxy) are functional in eliminating SA infection using a rat
tibia SA infection model (Ren et al., 2012). Specifically, we determined whether NF
coatings at current Doxy loading and drug release dynamics are sufficient to inhibit SA
infection over a period of up to 8 weeks. We propose that Doxy released from NF
coatings can be delivered to the infected surface of the implants and exerts its
antibacterial activity for up to 8 weeks. We prepared electrospun Doxy‐doped NF
scaffolds on the surface of Ti pin that were used in this rat tibia SA infection model.
Doxy is a tetracycline class broad‐spectrum antimicrobial agent effective against
variety of bacteria, including SA (Zhang et al., 2007). The effects of Doxy on bone
modeling have been investigated (Zhang et al., 2007; Park, 2012). Doxy inhibits
osteoclast activity. We previously demonstrated that Doxy effectively inhibited implant
wear‐ induced osteoclast activity and osteolysis in a mouse model(Zhang et al., 2007).
Franco et al.(Franco et al., 2011) studied the mechanism of action of Doxy in this regard,
and found that Doxy reduces RANKL‐ induced osteoclast formation by its inhibitory
effect on matrix metalloproteinase (MMP‐9) activity that is independent of the MAPK‐
NFATc1 signaling cascade. Doxy promotes osteoblast differentiation (Park, 2012) and
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enhances bone healing. Waleed et al.(Al‐Ali et al., 1989) reported that an
augmentation of new bone formation was achieved in a dog ligature‐induced bone
defect model when a combination of Doxy and tricalcium phosphate was applied. Park
et al.(Park, 2012) investigated the effect of Doxy on the viability, differentiation, and
mineralization of murine preostoblastic MC3T3‐E1 cells. They found that Doxy
treatment has no effects on the morphology, viability and growth of these cells.
However, a marked increase of alkaline phosphatase (ALP) activity was noticed in
Doxy‐ treated cells as compared to cells without Doxy treatment. In addition, Doxy
increased the production of bone morphogenetic protein‐2 and phospho‐Smad1/5
expression. To avoid the side effects of Doxy, such as gastrointestinal disturbance,
candidiasis, and vestibular concerns, a lasting and controllable local Doxy delivery is
highly desired. We propose that a local delivery of Doxy through the core‐sheath NFs
represents a new approach for the prevention of implant infection and augmentation
of implant osseointegration. It was reported that a high dose of Doxy (>0.5 mg/ml)
inhibited the growth of osteoblasts(Almazin et al., 2009). Therefore, we incorporated
a lower amounts of Doxy (100 μg/ml) into the core‐sheath NFs. We determined the
appropriate dose and release dynamics of Doxy from these NFs and the therapeutic
efficacy of Doxy‐doped NFs in treating SA‐infected implants in a rat tibia implantation
model.
In this study, we used a rat tibia implantation model (Allen et al., 1996; Ren et al.,
2010). Titanium (Ti) pin was inserted into the proximal tibia. This model is simple and

111

highly reproducible. This model has been widely used for the evaluation of implant
osseointegration by local drug delivery (Back et al., 2012; Song et al., 2010b) and
implant surface modification (Cheng et al., 2012; Diefenbeck et al., 2011; Raquez et al.,
2011).
Rat tibia implantation model with bacterial infection is an established model to
mimic periprosthetic infection (Monzon et al., 2001; Lucke et al., 2003; Schmidmaier
et al., 2006). Periprosthetic infection can be initiated by the inoculation of a bacterial
suspension at the site of infection in order to produce biofilms (Power et al., 1990) or
the use of a pre‐colonized implant (Ward et al., 1992). Mixed‐models, involving the use
of both a pre‐colonized implant and a bacterial suspension (Gracia et al., 1998) were
reported to reproduce the clinical use of infected implants and bacterial suspensions
of washing solutions at surgery and systemic infections. One limitation of the mixed
models was difficult to distinguish the biofilm formed on the implant from that of the
inoculated bacterial suspension. Therefore, we used a pre‐colonized implant approach
(Monzon et al., 2001) in reproducing a chronic biofilm infection in implant and bone,
thus being suitable comparative studies on antibiotic performance. An appropriate
bacteria inoculation (colony‐forming units, CFU) is to maintain the rat infected without
significant systemic toxicity. Previous studies showed that inoculation of S. aureus in
the dosage between 102– 106 CFU showed similar histological changes (Lucke et al.,
2003). In some of these models the number of bacteria used in the inoculated biofilms
can be as high as 108 CFU (Gracia et al., 1998) in the tibia implant site without
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significant systemic symptoms (Ren et al., 2012)
Materials and methods

Preparation of Ti pins with NF coating
We prepared coaxial electrospun PCL/PVA NFs on the surface of the Ti pin
(diameter 1 mm, length 10 mm) with defined thickness (~ 50 μm), covering the entire
surface of Ti pin stem. Ti pins coated with Doxy (100 μg/ml) ‐ doped NF scaffolds (both
at core and sheath layers) were sterilized under UV light overnight, and stored in 70%
ethanol briefly and air dried right before surgery.
In details, 10% (w/v) PCL solution was prepared by dissolving 0.5 g of PCL in 5 ml
of dimethylformamide (DMF)/chloroform (1:1,v/v).
prepared by dissolving PVA in distilled water.

The 10% PVA solution was

To encapsulate the Doxy into the

nanofiber, a stock solution (50 mg/ml in distilled water) of doxycycline hyclate was
prepared. Doxy solution was mixed with both PCL (sheath) and PVA (core) gel solution
right before electrospinning (final concentration 100 μg/mL in both solutions). Coaxial
electrospinning was performed using a custom made coaxial nozzle consisting of a
hollow stainless steel t‐junction with a fully penetrating 19‐gauge core needle. The
PVA solution (for core fiber) and PCL solution (for sheath) were uploaded to the
syringes. The syringes were attached to syringe pumps set at a flow rate (Q) of 0.5
ml/h. An 18 kV voltage was applied to the needle from the power supply. The distance
from needle tip to collector was 10 cm. A rotational speed of 500 rpm was used to
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evenly deposit the formed nanofiber on the Ti pin attached to the stainless steel
hexahedron collector, which was linked to the shaft of a motorized stirrer. For this in
vivo study, we deposited electrospun PCL/PVA NFs directly on the surface of Ti pins
(diameter 1 mm, length 10 mm) covering the entire surface of the Ti pin stem. The
thickness of the NFs coating is ~ 50 μm, measured by a micrometer and SEM. Ti pin
with NFs coating were sterilized by UV light overnight right before implantation. We
found that UV irradiation is a very effective sterilization method and has least effects
on the morphology and structural properties of NF structures.
SA inoculation
Ti pin placed in tubes containing 2 ml of a stationary culture of SA (1 X104 CFU).
Bacterial colonization was developed on the surface of the Ti pin for 12 h at 37°C.
Colonized Ti pins were recovered under sterility and washed with sterilized PBS to
remove unbound bacteria right before implantation. The number of clonorized
bacteria was determined in the control Ti pin which weren’t implanted. Ti pin without
inoculation of SA included as controls. To quantify a possible loss of viable bacteria
after freeze–thaw cycles the CFU was

Rat groups
Group

n

Description

reconfirmed

after

each

cycle

of

defrosting.
I

24

NF, no SA (control)

II

24

NF, with SA
Experimental design

III

24

Doxy‐NF, with SA

A total of 72 rats (300g‐400g) were
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used in this study. Rats were divided into 3 groups (Table). Each group included 24 rats
(8 rats for each time point). Under anesthesia, the right knee region was shaved and
sterilized with 70% ethanol. A 10 mm medial parapatellar incision was made to expose
the patellar tendon. The patella was dislocated laterally to expose the tibia plateau. A
pilot hole was drilled through the intercondylar eminence and a 1.0‐mm titanium pin
was gradually twisted to make a channel from the proximal tibial metaphysis into the
medullary canal. Right before Ti pin implantation, an inoculation of SA (1 X104 CFU
in 10 μl of saline) or the same amount of saline only (control) was delivered into the
bone marrow cavity.

Our previous studies showed that inoculation of SA in the

dosage between 1 x102– 1 x106 CFU showed similar histological changes of
osteomyelitis and bone loss. The CFU was confirmed by several plate counts with the
use of a spiralplater. Suspensions was split into portions and deep frozen at ‐80°C until
the day of surgery. To quantify a possible loss of viable bacteria following the freeze–
thaw cycle the CFU was reconfirmed after each cycle of defrosting. In addition, a 10
μL sample of inoculants was analyzed to determine the bacterial concentration in each
rat inoculation. Ti pin deposited with PCL/PVA NFs was inserted into the channel until
beneath the growth plate.

After implantation of Ti pin into the proximal tibia,

wounds were cleaned before being closed by suture in layers. μCT scans was
performed right after surgery to provide baseline information of periprosthetic bone
volume. Rats sacrificed at 4, 8 and 16 weeks after surgery, respectively. We propose
that Doxy released from NFs remains its bactericidal activity for 4 weeks or longer in
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the presence of slow‐degrading PCL sheath fibers. We propose to extend our
investigation up to 16 weeks. It is crucial to understand whether Doxy‐loaded NF
scaffolds are still effective in inhibiting infection up to 16 weeks during bone
remodeling phase. During the entire experiment, rats were monitored for the signs of
systemic infection and side effects. The outcome measures include microbiologic
testing, histology, mechanical pullout test and μCT/PET scan. Rectal body temperature
was measured with a digital thermometer and body weight was determined every two
days. We recorded the clinical signs of infection (swelling and reddening of the right
hind leg, loss of passive motion in knee and ankle joints).
Sample preparation
Rat tibia samples were collected and fixed in 70% ethanol immediately. After
fixation, samples were scanned with μCT. Then the specimens were cut transversely
using a diamond saw into two equal parts covering the entire length of the implanted
Ti pins (approximately 0.5 cm for each part). The proximal part (with rod head) was
used for the push‐in test. The distal part was used for the microbiological and
histomorphometrical evaluation. The specimens were randomly allocated a code
number, which was unknown to the observers for the treatment of the specimen
during tests and analysis.

Histomorphometry
The distal tibia bone segments (including part of the Ti pin) were fixed and
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dehydrated in graded ethanol (70‐99%). Specimens then were placed in 99% propanol
before being embedded in cold PMMA without decalcification. Perpendicular to the
tibia shaft, each specimen was sectioned in 100‐um thick slices using a rotary diamond
saw. The sections were ground to a thickness of approximately 30 μm, and then stained
with 1% toluidine blue. Bone‐to‐implant contact (BC) was calculated as the linear
percentage of the interface with direct bone‐to‐implant contact to total interface of
the implant in the cancellous bone. Bone area ratio (BA) was measured as the area
percentage of bone tissue to the whole area, which was defined as a ring extending
200 μm from the implant surface.
MicroCT (μCT)
Rats were scanned right after surgery (baseline) and repeated at sacrifice at
different time points (4, 8 and 16 weeks after surgery) using a μCT scanner (vivaCT 40).
The scanning system was set to 70 kV, 114 μA, 700 ms integration time at 40 μm
resolution, for maximal signal‐to‐noise ratio and maximal X‐ray transmission through
the Ti pins. A procedure for multi‐level threshold data acquisition (threshold for bone
‐205 and threshold for implant ‐700) was applied to discriminate bone from other
tissues. The reconstructed three‐dimensional (3‐D) images were utilized for
quantitative evaluation of osseointegration. The volume of interest (VOI) included the
trabecular compartment around the implant starting from 2.0 mm below the growth
plate and extending distally for 100 slices; it also include a ring with a radius of 200 μm
from the implant surface. After segmentation, the bone volume per total volume
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(BV/TV), the mean trabecular thickness (Tb.Th), the mean trabecular number (Tb.N),
the mean trabecular separation (Tb.Sp), and the mean connective density (Conn.D)
were assessed within the VOI zone. The % VOI was calculated as the ratio between
bone and total voxels in direct contact with the implant.
Reduction of metallic artifacts
Ti pin‐ induced metallic artifacts around periprosthetic bone tissue are a
challenging. To reduce the metallic artifacts in reconstructed CT images, we (1)
repeated the CT scan after the removal of the Ti pin by the pullout test, and (2)
Analyzed μCT data on defined sections of bone (1 mm) distal to the tip of the Ti pins in
the tibia, as we have described before (Ren et al., 2010).
Push‐in test
The proximal parts (with Ti pin head) of tibia samples used for push‐in testing.
Soft tissue around the tibia was removed to expose the surface of the implanted Ti pin
head and proximal tibia. The dorsi side of the tibia sample was then fixed into a self‐
manufactured aluminum fixture with a central cylindrical hole, as shown in Fig.36 (c).
The inserted tibia was stabilized by facilitated screws from four directions.
Approximate alignment was achieved by positioning the tibia parallel to push‐in probe
with the loading axis of the Instron model 8841 Universal Materials Test Machine.
Proper specimen alignment was obtained by adjusting the two rotational axes of the
fixture while using continuous fluoroscopy to confirm perpendicularity of the rods with
respect to the fixture base. Once the fixture is attached to the load cell, the fixture
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aligned along the x‐axis and y‐axis cross slides to obtain alignment between the
extraction pin and the implants. Under position control, the Instron 8841 actuator
pushed the Ti pin into the bone marrow at a rate of 1 mm/minute. Actuator position
and load were recorded by a PC using software. The Ultimate Shear Strength (the peak
push‐in force) and energy for complete pin push in (integration of push‐in force and
displacement) was used to reflect the osseointegration of interface.
Microbiological analysis
Ti pin was removed and washed with 0.5 ml sterile saline before SEM analysis.
Bone marrow cavity was washed with sterilized PBS three times and the washouts
were collected. To determine the bone SA contamination, a piece of tibia bone was
chilled with liquid nitrogen, followed by pulverization in a sterile bone mill. 150 mg of
bone powder was agitated in 1.5 ml of sterile PBS for 2 min by vortex and the
suspension was centrifuged for 10 s (10,000 rpm). 100 μl of the supernatant was used
for the bacterial assay. Washouts from bone marrow, Ti pins and extracts from bone
tissue were used for microbiologic analysis. A quantitative bacteria growth assay was
used to measure bacteria growth. We used SEM to determine whether the ingrowths
of SA on the Ti pin surface are inhibited by Doxy treatment.

Data Processing and Analysis
The following assumptions, based on our previous publication, are applied to the
power calculation: (a) bactericidal activity (OD at 625 nm of bacterial culture medium)
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varies from zero to 0.8 among groups; (b) the variations of histomorphometric
variables (Bone‐to‐implant contact and Bone area ratio) are >30%; (c) the changes
of the ultimate shear strength of the interface found at a pullout test (peak push in
force (N) and energy for complete pin movement (N‐mm)) varies between 30‐70%, and
(d) the variables of μCT (BV/TV, Tb.Th, Tb.N, Tb.Sp, Conn.D, and the % VOI ) varies from
25% to 70%. Each group contained 8 rats per time point.

Data was expressed as

mean± standard error of the mean for each group. A p‐value of less than 0.05 was
considered as a significant difference. Procedure mixed (PROC MIXED) in SAS used for
data analysis. When the assumptions of repeated measures ANOVA are not realized
for some response variables, the generalized estimating equation was used.

Results:
Push‐in test

e (N)

45
40
35
30

*

*

*
#

*

*
#

No Bacteria
With Bacteria
With Bacteria
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Fig.40 Rat tibia implanted Ti‐pin push‐in test. (a) Push‐in force. Rat tibias were
harvested from different time points (4, 8, 16 weeks). n= 5. p*< 0.05 represents
significant difference between different time points within group. p#< 0.05
represents significant difference between different groups within the same time
point. Representative image of (b) push‐in test and (c) harvested rat femur with Ti‐
pin.
As shown in Fig.40, at 4 week time point, non‐Doxy groups w/ SA group showed the
lowest push‐in force, showing a weak bonding between NF and surrounding bone
tissue, which was considered as the result of SA‐ induced osteomyelitis. Doxy groups
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w/ SA obtained the significant highest push‐in force, showing a promising bactericidal
effect to prevent loosening. At 8 week time point, push‐in forces of all groups were
significantly increased (p<0.05). Doxy group w/ SA still has the highest push‐in force,
and non‐Doxy group w/ SA was the lowest. The incorporation of Doxy significantly
inhibited the SA‐induced osteomyelitis (p<0.05) in 8 weeks. However, the situation
changed at 16 week time point. Non‐SA group (control) showed the highest push‐in
force, and other two groups with SA inoculation decreased drastically (p <0.05). This
result indicated the incorporated Doxy was either completely released or failed after
16 week, which caused remaining SA grew back to affect the bonding.

Though SA‐

induced osteomyelitis was observed in both groups at 16 weeks, Doxy group showed
stronger bonding with bone in comparison with non‐Doxy group (p< 0.05). This test
confirmed that Doxy incorporated NFs was able to maintain the stability and local
delivery efficiency of antibiotics, which inhibited SA activity for 8 weeks. The
bactericidal activity of Doxy incorporated NF could prevent the infection induced
osteomyelitis in early stage (within 8 weeks).
MicroCT analysis
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(a)

(b)
Fig.41 Representative (a) 3D and (b) 2D reconstructed images of rat tibia bone
morphologic change during implantation. Arrows: Ti pin.
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The interface of NF coated Ti pin and surrounding bone tissue was analyzed by
MicroCT (Scanco Viva CT 40, Scanco Medical, Switzerland). The 3D morphology of the
tibia was reconstructed using built‐in software and key parameters including bone
volume fraction (BV/TV) and Trabeculae separation (Tb.Sp) were measured to
characterize the SA‐induced osteomyelitis and the therapeutic effect of NF‐coatings
with incorporated Doxy. In consistence with the push‐in test, micro CT showed similar
result. Representative 3D and 2D images with morphological change of rat tibia
implantation in time course were shown in Fig. 41 (a) and (b), respectively. A typical
plane cut in vertical direction to expose the implanted Ti‐pin and surrounding bone
tissue was adopted during 3D reconstruction. For NF (control) group, a gradual
improvement of bone volume around Ti pin and bonding between bone mineral and
Ti around the interface can be observed from 0 week to 16 week. This change can be
viewed more clearly from 2D image (Fig. 41 (b)). It indicated the self‐ remodeling
mechanism of bone when defect was occurred. In other hand, NF + SA group showed
a huge morphological change from 0 week to 4 week. At 4 week, the bone volume in
implanted area was significantly reduced in 3D image, and a huge gap between Ti and
bone tissue can be viewed in 2D image. After 16 weeks, the bone loss hasn’t been
recovered and Ti pin was shown to be loosening and have very week bonding with
surrounding bone. For NF + SA + Doxy group, the SA induced osteomyelitis was largely
alleviated. After implantation for 4 weeks, new trabeculae bone was started to form
around Ti pin and the bone volume was constantly increased. The gap between Ti and
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bone is not observed during implantation. More quantified parameters were shown to
elucidate the effect of Doxy incorporation against SA‐induced infections as below.

8

16

8

16

8

16

Fig. 42 Quantitative results of micro‐CT scans for rat tibia implanted with NF‐coated
Ti‐pin (NF, control), NF‐coated Ti‐pin with inoculation of S. aurous (NF + SA) and
doxycycline incorporated NF‐coated Ti‐pin with inoculation of S. aurous (NF+SA+
Doxy). All rats were scanned every 4 weeks. Bone volume fraction was presented via
percentage of bone volume/ total volume (BV/TV %). BV/TV change slope was
obtained by linearly fit the data. n= 8. p*< 0.05 represents significant difference.
As shown in Fig.42 (a), Non‐SA group (control) presented a recovery progress in
bone volume from 4 week to 16 week after implantation. Non‐Doxy with SA group (NF
+ SA) showed similar trend, however, with much slower recovery rate (table). As shown
in Fig. (c), Doxy with SA group (control) presented a rapid recovery progress in bone
volume from 4 week to 16 week after implantation. BV/TV values at 8 weeks and 16
weeks shows significant elevation in comparison with 4 weeks (p<0.05). From the
linear fitting result as shown in table in Fig. 42, NF + SA group only obtained a slope of
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BV/TV change of 1.0738 at 8 weeks and 0.2882 at 16 week, which is much lower than
both control group (1.8358 at 8 weeks and 0.7116 at 16 week) and NF + SA + Doxy
group (2.1641 at 8 weeks and 0.6548 at 16 week). With the influence of incorporated
Doxy, the recovery rate of bone volume in the presence of SA is significantly
accelerated, which is closed to the normal bone defect recovery (control)

Fig. 43 Quantitative results of micro‐CT scans for rat femur implanted with NF‐coated
Ti‐pin (NF, control), NF‐coated Ti‐pin with inoculation of S. aurous (NF + SA) and
doxycycline incorporated NF‐coated Ti‐pin with inoculation of S. aurous (NF+SA+
Doxy). All rats were scanned every 4 weeks. Trabecular Separation (Tb.Sp) which is
the measurement of the space between the trabeculae was quantified and plot
against implantation time points. n= 8. p*< 0.05 represents significant difference.
Trabecular Separation (Tb.Sp), which is the measurement of the space between
the trabeculae, was also used to evaluate bone volume changes. Higher value of Tb.
Sp means the larger space between trabeculae, showing another evidence of
loosening and resorption in bone volume. As shown in Fig. 43, NF + SA group has a
significant elevation in Tb. SP after every 4 weeks during implantation (p<0.05),
whereas no difference was found for control groups during entire implantation period.
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Moreover, NF + SA group obtained the highest value in each time point after 4 weeks
of implantation. This result also confirmed that SA induced significantly bone loss and
weak bone structure, which consisted with the data from prior push in test. For NF +
SA + Doxy group, however, no difference in Tb. Sp was found up to 16 weeks. This result
is also consistent with push in test for the sudden descending force at 16 week time
point, which has been discussed as the reason of doxy failure. Nevertheless,
incorporated Doxy was able to prevent SA‐induced osteomyelitis up to 8 weeks, which
prevents the bone loss and implant failure in early stage.
Microbiology analysis

(a)

(b)
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(c)
Fig. 44 Microbiology assay. (a) SA growth on harvested Ti‐pin implanted in Rat tiba.
(b) SA growth in washout medium. +, positive growth; ‐, negative growth. (c) SEM
morphology of SA growth on harvested NFs from Pin surface (16 week). Left: NF +
SA; Right: NF+ SA + Doxy. Black arrows: SA formed biofilm; Yellow arrow: NFs
We performed microbiological assay on harvested Ti pin and washout solution
from bone marrow in order to further confirm the bactericidal effect from Doxy‐
incorporated NF coatings. As shown in Fig.44, at 8 week time point, Ti pin harvested
from NF + SA groups showed obvious bacteria growth in agar plate, whereas NF + SA
+ Doxy groups have no sign of bacteria growth. The semi‐quantitative result of
washout test was quite consistent, as shown in Table in Fig.44. A 2 out of 5 positive
result of positive bacteria activity was obtained from bone marrow washout of NF +
SA group, whereas no positive result was given from NF + SA + Doxy group. At 16 week
time point, more bacteria growth could be observed in surrounding of Ti pin from NF
+ SA group, whereas much less of bacteria was found for NF + SA + Doxy group. Assay
on washout showed similar result. All 5 samples were positive for NF + SA group,
whereas only 2 out of 5 were positive for NF + SA + Doxy group. This result further
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demonstrated Doxy incorporated NF coating was very effective to inhibit bacterial
infection for 8 to 16 weeks. Moreover, the morphology of SA from SEM also confirmed
the formation of biofilm from richer and outnumbered SA colonies on Non‐Doxy NFs,
as shown in Fig. 44 (c). Doxy contained NFs were still easy to differentiate due to less
adhered bacteria.
A bacteria activity assay on SA on Ti‐pin samples in vitro was performed to
confirm the viability of SA after growing in dried condition at room temperature for 45
d, as shown in Fig.45. The positive results of SA activity on Ti sample indicated the
viability of SA is affirmative for a long‐term period.

Bacteria activity (OD)

0.7
0.6

*

Bacteria activity in vitro

0.5
0.4
0.3
0.2
0.1
0

Pin with NF only

Pin with NF+Doxy.

Fig. 45 The activity of SA seeded on Ti pin surface was evaluated: SA seeded Ti pin
+ NF and SA seeded Ti pin + NF + Doxy were dried and placed at room temperature
for 45 d. Then the Bacteria activity (OD) was measured to exclude the possibility of
SA self‐apoptosis. *P<0.05.
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Discussion

S. aureus is one of the most common pathogens found in periprosthetic infection.
Surgical procedure of treating periprosthetic infection and osteomyelitis is to remove
infected bone and soft tissue, which leaves large space that eventually cause instability
of implant. In our push‐in test, this situation was observed in NF + SA group that
bonding between implant and bone is extremely weak.

Numerous attempts have

been made by researchers in order to overcome this problem. The most efficient way
is developing a local delivery system that enables the implant to release antibiotics in
a sustainable manner. Sustainable release of antibiotics from local delivery device
could effectively prevent bacterial colonization in the early stage and is advantageous
in releasing drug directly to the implanting area in prolonged period, which alleviates
systemic toxicity. The challenge in clinical treatment on osteomyelitis is to determine
an optimal therapeutic outcome with effective drug dosage. In this study, we explored
an approach by incorporating certain amount of antibiotics to effectively prevent
osteomyelitis in early stage of implantation without interrupting the self‐ bone
remodeling.
A desired local drug delivery system should deliver antibiotics well above their
minimum inhibitory concentration (MIC) in a sustainable manner (Mourino and
Boccaccini, 2010; Lepretre et al., 2009). A period of up to 6 weeks is required for a full
vascularization of bone grafts implanted in segmental defects to occur(Geiger et al.,
2005).

Therefore, a sustained antibiotics release exceeding the MIC for at least 6
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weeks is highly desirable for the treatment of osteomyelitis(Simchi et al., 2011b).
There is a big challenge to develop bactericidal bone scaffolds with controllable
sustained release of active antibiotics(Mourino and Boccaccini, 2010). Several
attempts have been made to reach a desired local drug delivery(Simchi et al., 2011b;
Baroli, 2009).
According to the preliminary studies, Doxy incorporated PCL/PVA coaxial
nanofiber has shown to be effective in inhibiting bacteria growth in vitro. Incorporated
Doxy followed a zero‐order sustainable release that can continue for over 30 days
(Fig.31) and enable to inhibit bacteria growth for over 10 days. Our result from the rat
tibia implantation model study further supported the in vitro data. The bactericidal
effect from Doxy incorporated NF coating was sustained for 8 weeks, which already
exceeded the standard requirement of total duration of 4‐6 weeks of parenteral
therapy for osteomyelitis. There was no obvious systemic toxicity caused by Doxy
during the implantation. In our experimental design, 100 μg/mL of Doxy for preparing
NF coating is quite modest. There has more potency to incorporate higher dose of Doxy
that possess longer therapeutic effect against osteomyelitis.
Micro CT imaging technology is particular useful in study the biological process of
bone remodeling. The reconstructed 3D and 2D images in combined with quantitative
data (BV/TV, Tb. Sp) were used to evaluate the bone mineral change at the site of
proximal tibia in containing of infected Ti pin. In contrast, Doxy incorporated NF
induced a higher bone density and new trabaculae formation surrounding implant
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within 8 weeks duration of experiment. It is noted that timely measurements of micro
CT represent a cost‐effective and accurate approach to monitor each individual rat for
the infected bone density change.
One thing need to be noted is the growth back of bacteria after 8 week of
implantation. As we discussed previously, the release of Doxy from PCL/PVA coaxial
NFs could sustained for over 30d, which was in consistent with the in vivo study that
bacteria activity was suppressed for 4‐8 weeks. Doxy released from NFs could still be
active for a period to inhibit bacteria activity. However, the dose of Doxy applied in NFs
from this study may not be sufficient for extending to over 8 weeks. Therefore, SA was
growing back from expiration of Doxy after 8‐16 week of implantation. In future study,
more Doxy could be incorporated to further explore the optimal inhibitory efficacy
against SA infection.
In summary, Doxy incorporated PCL/PVA coaxial NFs could sustainably and locally
deliver Doxy and effectively prevent the bacteria adhesion on Ti implant surface. This
bactericidal efficacy of surface coating NFs last for over 8 weeks and successfully avoid
the osteomyelitis, which demonstrated to be a very efficient alternative to overcome
the infection of orthopaedic prosthesis.
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Chapter 8 Conclusions
Since the total joint replacement (TJR) has been widely applied for about century,
TJR surgery currently has very high successful rate. Each year, over 700,000 total joint
replacement (TJR) operations (hip and knee) are performed in the US, and this number
is still constantly increasing due to the elevated requirements of pursuing high quality
life from patients. However, the TJR is far away from perfection, especially from a
long‐term perspective, as already addressed in our study. Multi‐factors induced
loosening (mainly categorized into septic and aseptic) caused a large proportion of TJR
implant failure. The revision surgery or secondary replacement represents a high cost
and suffering to patients, which urges researchers to explore new technologies for
overcome these problematic issues. Current approaches, including cemented,
cementless, press‐fit fixation, biological coatings with antibiotics cannot completely
prevent implant loosening, especially during long‐term implantation. Lack of
osseointegration for interface between implant and surrounding bone, wear debris of
implant materials and osteomyelitis are major issues to induce implant loosening.
Therefore, developing a biocompatible, bioactive and bactericidal interface between
bone and implant becomes a crucial approach for preventing implant failure.
We initially proposed a hydrogel system incorporated bone components (PVA‐
Col‐HA gel) with local delivery capability as a coating material on implant surface. It
has been demonstrated that PVA‐Col‐HA gel system is tunable in physiochemical
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properties and advantageous as follow:


Excellent biocompatibility that induced bone cells adhesion and proliferation



Great capability to load and sustainable delivery of antibiotic that effectively
inhibit bacteria growth and osteoclastogenesis
Components (PVA, HA, Col) used in this study were proven to be excellent

candidates for implant surface modification. However, the limitations of this system
are obvious:
 The bonding between PVA gel and bone is still weak
 The dense or nonporous structure of the gel prevented cell infiltration, which
hindered the later osseointegration.
 The distribution of HA and Col is inhomogeneous, and the particle scale is not well
matched for cell interaction.
Thus, in order to improve the surface modification method, we proposed
electrospun nanofibers as surface coating matrix in our study. Electrospinning
technology for manufacturing fibrous mat in nano scale has been introduced in
biomedical field for decades. However, the application in orthopaedic field is rare. Our
idea to utilize this new technology for solving old problems in TJR surgery is quite
innovative. We firstly fabricated monolithic PVA‐Col‐HA electrospun nanofibers, for
which components are all introduced from previous hydrogel study. The improvements
of these monolithic NFs are significant:


Tunable highly interconnected porous structure in this fibrous scaffold
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Capable of incorporation nano‐HA and Col, and the distribution of embedded
components are more homogeneous.



Improvement in cell adhesion and proliferation
However, we still found limitation from monolithic PVA‐Col‐HA electrospun

nanofibers:


The fast hydrolysis or degradation of PVA fibers ruled out the possibility of
sustained delivery of drugs to inhibit bacteria growth in a long‐term period.

Therefore, we further developed a coaxial electrospun nanofibers (NFs) system
(PCL/PVA) with a hydrophobic sheath (PCL) and hydrophilic core (PVA) structure to
prolong the degradation of nanofibers. The unique physiochemical properties and
bioactivities have demonstrated that coaxial NFs an excellent surface modification
material on implant surface:


Prolonged degradation of PCL sheath enables the controllable and sustainable
release of incorporated drugs.



Stiffer surface modulus enhanced bone cell adhesion that benefits
osseointegration



Significance in bactericidal effect to prevent bacteria colonization in vitro

Once we thoroughly studied the physiochemical properties and bioactivities of
coaxial NFs in vitro, a series of in vivo study were carried on. A well‐established rat tibia
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implantation model was utilized to evaluate the feasibility of coaxial NFs as a coating
material on implants. The results of this in vivo study show PCL/PVA coaxial NFs as
promising coating materials for TJR implants as follow:


Coaxial NFs enhanced the osseointegration from surrounding bone to implant



The bonding between implant and bone was reinforced



Osteomyelitis was prevented since antibiotics can sustainably release from NFs to
inhibit bacteria growth in early stage of implantation
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ABSTRACT
DEVELOPMENT AND APPLICATION OF BIOMIMETIC ELECTROSPUN NANOFIBERS IN
TOTAL JOINT REPLACEMENT
by
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Failure of osseointegration (direct anchorage of an implant by bone formation at the
bone‐implant surface) and implant infection (such as that caused by Staphylococcus aureus, S.
aureus) are the two main causes of implant failure and loosening. There is a critical need for
orthopedic implants that promote rapid osseointegration and prevent bacterial colonization,
particularly when placed in bone compromised by disease or physiology of the patients. A
better understanding of the key factors that influence cell fate decisions at the bone‐implant
interface is required. Our study is to develop a class of “bone‐like” nanofibers (NFs) that
promote osseointegration while preventing bacterial colonization and subsequent infections.
This research goal is supported by our preliminary data on the preparation of coaxial
electrospun NFs composed of polycaprolactone (PCL) and polyvinyl alcohol (PVA) polymers
arranged in a core‐sheath shape. The PCL/PVA NFs are biocompatible and biodegradable with
appropriate fiber diameter, pore size and mechanical strength, leading to enhanced cell
adhesion, proliferation and differentiation of osteoblast precursor cells. The objective is to
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develop functionalized “bone‐like” PCL/PVA NFs matrix embedded with antibiotics
(doxycycline (Doxy), bactericidal and anti‐osteoclastic) on prosthesis surface. Through a rat
tibia implantation model, the Doxy incorporated coaxial NFs has demonstrated excellent in
promoting osseointegration and bacteria inhibitory efficacy. NFs coatings significantly
enhanced the bonding between implant and bone remodeling within 8 weeks. The SA‐induced
osteomyelitis was prevented by the sustained release of Doxy from NFs. The capability of
embedding numerous bio‐components including proteins, growth factors, drugs, etc. enables
NFs an effective solution to overcome the current challenged issue in Total joint replacement.
In summary, we proposed PCL/PVA electrospun nanofibers as promising biomaterials that can
be applied on joint replacement prosthesis to improve osseointegration and prevent
osteomyelitis.
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